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Abstract
CYCLIC-DI-GMP SIGNALING IN THE BORRELIA SPIROCHETES
By John Courtland Freedman
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University 2011
Major Director: Richard T. Marconi, Ph.D.
Professor, Department of Microbiology and Immunology

Lyme disease is the most common tick-borne disease in North America, with
approximately 35,000 cases reported to the Centers for Disease Control in 2008. The
genome of its causative agent, Borrelia burgdorferi, encodes for a set of genes involved
in the metabolism and regulatory activities of the second messenger nucleotide, cyclicdi-GMP (c-di-GMP). Rrp1 is a response regulatory-diguanylate cyclase, and its
regulatory capability is likely mediated via production of c-di-GMP, as it lacks a DNAbinding domain. One known class of c-di-GMP effector/binding proteins are those that
harbor a PIlZ domain. The genome of B. burgdorferi strain 5A4 encodes for one
chromosomally-carried PilZ domain, which we have designated PlzA. Additionally,
certain B. burgdorferi strains encode for a second PilZ domain-containing protein (PlzB)
which is plasmid-carried. Both PlzA and PlzB were found to bind specifically to c-diGMP, and c-di-GMP binding by PlzA was found to be dependant upon arginine residues
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xv

in the c-di-GMP binding region. Additionally, expression of PlzA was found to be
upregulated by tick feeding and was constitutive in the mammalian host. We next
constructed two deletion/allelic exchange mutants – one with the targeted deletion of
PlzA, and on ethat replaced PlzA with PlzB in a strain lacking the plzB gene. Our
studies demonstrated that !plzA was deficient in motility and was also non-infectious in
the mouse model of B. burgdorferi infection. Additionally, this strain remained viable in
larval Ixodes ticks. Also, B31-plzB KI was deficient in motility, as well as infectivity,
demonstrating that PlzB is unable to complement for functions fo PlzA in vitro and in
vivo and that it may play other roles in the biology of B. burgdorferi strains carrying the
plzB gene. These studies represent the first identification of a c-di-GMP binding protein
in any spirochete, but also represent the first demonstration of the importance of PilZ
domain proteins in a spirochetal system. We additionally examined the effects of c-diGMP synthesis and breakdown in the related bacterium, B. hermsii, a causative agent
of tick-borne relapsing fever (TBRF). Deletion mutants in Rrp1 (B. hermsii’s sole
diguanylate cyclase) and PdeA (B. hermsii’s only EAL domain-containing
phosphodiesterase) were created. These strains were analyzed in order to determine:
1) the effect(s) of the losse of Rrp1/PdeA on intracellular spirochete c-di-GMP levels,
and 2) the effects of Rrp1/PdeA on the establishment of murine infection and on gross
motility/chemotaxis. It was demonstrated that c-di-GMP accumulates intracellularly in
the cells lacking PdeA. Additionally, spirochetes were shown to chemotax towards Nacetyl-glucosamine (NAG) and they did not form soft agar swarms. In contrast, cells
lacking Rrp1 did not accumulate detectable levels of c-di-GMP, demonstrated a reduced
ability to chemotax towards NAG, and swarmed on soft agar in a fashion
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indistinguishable from wild type. Despite these differences in phenotype, both mutant
strains display an attenuated murine infectivity. These results indicate that c-di-GMP is
indeed important in the TBRF spirochete, B. hermsii and this vital second messenger
plays key roles in virulence, motility, and chemotaxis. These studies also pave the way
for future investigation of B. hermsii through use of targeted genetic manipulation.
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Chapter 1: Introduction

Lyme disease
Lyme disease is the most common tick-borne illness in North America and
Eurasia, with approximately 30,000 cases reported annually to the Centers for Disease
Control (CDC) (32, 153). However, this figure is believed to be an underestimate of the
actual number of cases, as a result of physician misdiagnosis and noncompliance in
reporting. In 1975, the town of Lyme, Connecticut (CT) became an epicenter of
epidemiological study. Thirty-nine children within a small area of Lyme, CT were
diagnosed with symptoms of juvenile arthritis – the cause, unknown (156). Valiant
efforts and fervent communication between public health officials, physicians, and top
researchers of tick-borne illness, lead to the discovery in 1981 that Lyme disease was
caused by the spirochete, Borrelia burgdorferi (named after Willy Burgdorfer, its lead
discoverer) (14, 23, 154). Though it was known that the causative agent of Lyme
disease was tick-borne, it was confirmed that B. burgdorferi is transmitted by the bite of
infected Ixodes scapularis ticks (9). Almost thirty years later, Lyme disease researchers
have obtained a breadth of knowledge as to a number of molecular mechanisms that
underlie the ability of B. burgdorferi (as well as B. garinii and B. afzelii in Asia and
Europe) to establish and cause productive infection (152).
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Lyme Borrelia spp. exist in an enzootic cycle between hard-bodied ticks of the
genus, Ixodes, and a number of hosts including mammals and birds. It is important to
note that humans are accidental hosts of Lyme spirochetes. The ticks that transmit the
Lyme Borrelia are found worldwide, making Lyme disease a health hazard of global
concern. I. scapularis transmits B. burgdorferi in the eastern regions of the United
States (US), and I. pacificus transmits these organisms in the western US. The
species, I. ricinus and I. persulcatus, respectively, transmit disease in Europe and Asia
(4). The life cycle of Ixodes ticks falls in conjunction with the transmission of Lyme
disease spirochetes. Adult ticks lay eggs in the spring, which hatch into larval ticks in
the summer time. In the summer, the larvae take a blood meal on potentially infected
rodent, birds, or other animals. If the animal they feed upon is infected, they may
acquire the Lyme Borrelia. During the fall and winter, the now-infected larval tick
moults, and matures into the nymphal form. By spring, the nymphal tick is ready to take
another blood meal, and is capable of transmitting Borrelia to other animals, including
accidental human hosts. Following the same time line, nymphal ticks moult into adult
male and female ticks, which are then able to lay eggs in the spring, thus perpetuating
the tick life cycle. Importantly, transovarial transmission of the Lyme spirochetes does
not occur (Figure 1) (4).
Following the initial tick bite, the spirochetes begin to disseminate laterally
through tissues, initially causing an erythema migrans (EM) rash in 80% of patients. The
EM rash manifests itself as a ‘bull’s-eye’ pattern, with the center lesion at the site of the
tick bite being 5 - 6.8 cm in diameter. However, more often that not infected individuals
do not recall a tick bite (155, 171). The EM rash grows in diameter over
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Figure 1. The enzootic cycle of Borrelia burgdorferi. B. burgdorferi is maintained in
nature in an enzootic cycle between Ixodes spp. ticks and mammalian hosts. Shown is
the three stage life cycle of Ixodes scapularis. Larval, nymphal, and adult stages are
indicated. Larval, nymphal, and adult ticks take a blood meal in the seasons indicated
and where are shown in proximity to mammalian or avian hosts. Larval and nymphal
ticks undergo moulting and adult ticks lay eggs following the bloodmeal. Larval ticks
most commonly acquire Lyme Borrelia from the mammalian host, and nymphal ticks are
the most common to transmit Lyme Borrelia to other mammalian hosts, including
humans. See text for further detail.
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Image adapted from Centers for Disease Control
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time, with the final diameter reaching up to 12 inches in size. Concurrent with the EM
rash, are manifestations that include chills, fever, headache, myalgia, and arthralgia (7).
If left untreated, the motile spirochetes can enter into the vasculature and disseminate
into other tissues (106). Late stage manifestations of Lyme disease include arthritis,
dermatological, neurological, and cardiovascular disorders. Patterns of dissemination
may differ upon species and strains of the Lyme Borrelia, affecting the clinical outcome
of disease (104).
Lyme arthritis is reported in 60% of untreated cases, and is most commonly
reported unilaterally in the knees. Inflammation can be severe, and the accompanying
arthritis is the most common symptom occurring in US infection (50, 170). Unlike Gramnegative bacteria, the Borrelia do not produce lipopolysaccharide (LPS), and evidence
supports that the expansive array of membrane lipoproteins are responsible for the
inflammation (45, 142). The most common dermatological manifestation is
acrodermatitis chronica atrophicans (ACA), which manifests itself as a skin lesion,
typically on the backs of hands and feet. Initially, swelling of the skin occurs and later
hyper-pigments and atrophies. These symptoms are most commonly associated with
B. afzelii infection (70). Neurological manifestations (neuroborreliosis) are most
commonly found in those infected with B. garinii, and include meningitis and cranial
neuritis. Meningitis is the most common form of neuroborreliosis and symptoms include
headache, stiff neck, malaise, and photosensitivity. Cranial neuritis affects the cranial
nerve, and may additionally affect the facial nerve, causing unilateral facial palsy (Bell’s
palsy) (66, 108). Carditis also may occur, but is not associated with a specific species
of Borrelia (54, 131).
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Treatment of Lyme disease involves the use of antimicrobial therapy, with oral
doxycycline being the major drug utilized for early localized and/or disseminated
disease. Intravenous (IV) ceftriaxone is the antibiotic of choice for late stage and
disseminated infection (21, 50).

Tick-borne relapsing fever
Tick-borne relapsing fever (TBRF) is also caused by species of the genus
Borrelia. Three species have the potential to cause disease in North America (B.
hermsii, B. turicatae, and B. parkeri) and greater than 20 have the potential to cause
disease in Africa (73, 138). While instances of the disease are low in North America
(<25 cases/year), they are quite high in sub-Saharan Africa, with certain villages having
reported rates of up to 30%. Spread by the bite of infected soft-bodied tick vectors of
the genus Ornithodoros, TBRF has also been reported to be a top ten killer of youth in
these regions (42). In Africa, endemic and epidemic disease cases are associated with
conditions of drought, while in North America, most cases occur in mountainous regions
and are associated with campers staying in close proximity to Ornithodoros ticks in
rustic cabins and caves (87). Ornithdoros ticks are the major reservoirs of the TBRF
Borrelia and have a life cycle that differs from the Ixodes ticks. Differences are that the
Ornithodoros ticks undergo many nymphal blood meals and molts. Also, unlike Ixodid
ticks which feed for 24-48 hours, Ornithodoros ticks feed as quickly as 30-45 minutes.
As such, tick acquisition and transmission processes of the TBRF Borrelia are likely to
differ greatly from those species that cause Lyme disease (96).
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Also in comparison to Lyme disease, are the differing disease processes,
manifestations, and clinical outcomes of TBRF. TBRF Borrelia quickly gain entry into
the bloodstream following the tick bite. In fact, the hallmark of TBRF is high numbers of
spirochetes in the blood (up to 106 spirochetes/mL), which correlate with high fever,
malaise, and generalized “flu-like” symptoms (47). Due to allelic exchange of vmp
(variable major protein) gene cassettes on linear plasmids, the relapsing fever Borrelia
are able to express and present different Vmps on the surface, allowing escape from
the adaptive immune system. This form of antigenic variation allows for outgrowth of
Borrelia expressing previously unrecognized Vmp types in the blood. This outgrowth
correlates with the previously mentioned symptoms, and is responsible for the number
of relapses that occur over the course of disease. However, over time, the TBRF
spirochetes are typically cleared via the adaptive-humoral immune response by a
bacteriocidal and complement-independant IgM antibodies. (40, 77, 99, 121, 157).
Three to 10 relapses may occur over the course of infection, if left misdiagnosed or
untreated (33). Treatment of TBRF typically occurs with a 7 day course of doxycycline
(87, 168). In infection that is left untreated, many organ systems of the body can
become infected, with mortality most commonly being associated with myocarditis (27).

Borrelia
Species of the genus Borrelia are unique and highly diverse prokaryotic
organisms of the phylum Spirochaetes, which includes the genera Treponema and
Leptospira, also of human health significance. All Borrelia spp. share a common
cellular morphology (i.e. they appear as ‘spirals’), a segmented, and variable genome,
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and are dependent upon animal hosts for their survival in nature (10, 31, 36, 55).
Borrelia spp. can be grouped into several clades based upon their genetic makeup, thus
affecting the specific enzootic niche and disease that they cause. Borrelia spp.cause
Lyme disease (B. burgdorferi, B. afzelii, and B. garinii), relapsing fever (B. hermsii,
along with others), avian borreliosis (B. anserina), and epizootic bovine abortion (B.
coriaciae) (25, 56, 64, 73, 95, 98, 136, 141).
The ultrastructure of Borrelia spp. is unique in that they contain an inner
membrane, a single periplasmic layer of peptidoglycan, periplasmic flagella, and an
outer membrane with an expansive repertoire of lipidated proteins (46, 102, 120).
Within the inner membrane is the unique, segmented genome composed of a linear
chromosome of approximately 900 kb, and up to 21 linear and circular plasmids (30, 31,
43, 52, 55, 78, 89, 122). Though genetic organization is similar between Borrelia spp., it
is important to note that the chromosome encodes predominantly for housekeeping
proteins, while the plasmids predominantly encode for proteins involved in specific
disease processes (30, 31, 43, 52, 55, 78, 89, 122). Chromosomal organization is
maintained significantly between Borrelia spp., while plasmid repertoire may differ
greatly between species and strains. The genetic constituents of B. burgdorferi B31 are
shown in Figure 2. It is thought that the phenomena of plasmid repertoire/organization
play a role in disease manifestations and clinical outcomes. It is noteworthy that
Borrelia spp. have minimal metabolic capabilities. The limited de novo biosynthetic
capabilities of the Borrelia keep them restricted to a host-dependant lifestyle. Genomic
analysis indicates that they are homofermenters and rely on glycolysis with lactate as a
terminal electron-acceptor. Additionally, they lack the enzymes required for nucleotide,
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Figure 2. Genetic organization of B. burgdorferi. The genome of B. burgdorferi
consists of a linear chromosome of approximately 910 kilobase pairs. Additionally,
approximately 21 linear and circular plasmids are maintained by the organism. The
chromosome encodes predominately house keeping genes, while the plasmids encode
for genes important for host dependent processes. Plasmids shown in red have been
shown to be important in processes important in host infection.
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Adapted with permission from Stewart PE, Byram R, Grimm D, Tilly K,
Rosa PA, 2005. Plasmid, 53(1). (197).
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amino acid, and fatty acid biosynthesis, and must rely on transport of these compounds
from the host environment (55). These organisms encode for several ABC transporters
as well as P66, which is a pore-forming outer membrane protein (147, 148). There are
approximately 100 predicted proteins involved in transport across membranes. The
Borrelia also lack enzymes required for the TCA cycle, oxidative phosphorylation, and
lipopolysaccharide synthesis. ATP is generated from substrate level phosphorylation
and a V-Type ATPase in the inner membrane, as they lack an electron transport chain
(55).
Moving outwards is the periplasmic space which contains a single layer of
peptidoglycan and periplasmic flagella (35, 102). The flagella of the Borrelia form
helical bundles around the protoplasmic cylinder, which attribute to the cells a flat-wave
morphology and ability to be motile. Borrelia spp. have 2 flagellar bundles attached near
each end of the cell cylinder containing 7-11 flagellar filaments each. Flagellar filaments
extend towards the center of the cell, and it is believed that their rotation against the cell
cylinder allows the cells to gyrate and move through viscous media, and more
importantly, tissue during in vivo infection (Figures 3A and 3B) (34-36, 46, 81, 93).
Interestingly, while the Borrelia encode for homologs of most flagellar, flagellar motor,
and chemotaxis proteins found in other genera of bacteria, they encode for multiple and
heterologous copies of FliG (FliG-1 and FliG-2) as well as proteins involved in
chemotaxis (55, 62, 63). As is the case with other bacteria, the Borrelia use the proton
motive force to generate energy for gyration of the flagellar motors (143). Gyration of
the motors occurs at both ends of the cells. Simultaneous gyration in the
counterclockwise (CCW) or clockwise (CW) results in flexes/pauses, equivalent to the
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‘tumbles’ observed in rod-shaped bacteria such as the Enterobacteriaciae. When either
end of the cell rotates in opposing directions, the cell moves in the direction of the cell
pole that is turning CCW (Figure 3C). Typical Borrelia motility follows a pattern of a run,
followed by a flex/pause, followed by a reverse run (90, 160). It is thought that this
pattern of motility may be a result of the chemotactic response, important in homing of
the Borrelia towards attractants and away from repellants (8, 90, 144).
The outer membrane of the Borrelia displays an expansive repertoire of lipidated
proteins, important for survival in the tick vector, transmission from the tick vector to the
mammalian reservoir, and establishment/maintenance of mammalian infection (2, 84,
110, 119, 120, 140, 165, 175). Many of these outer membrane proteins are antigenic in
nature and it is believed that they may be responsible for inflammation encountered
during mammalian infection (11). Outer surface proteins important during tick
transmission and mammalian infection include Outer surface protein A (OspA), and
OspC. While these surface proteins are important for infection, many of the proteins
important for establishment of mammalian infection, as well as tick survival, acquisition,
and transmission from/to the mammal, are those involved in two-component regulatory
system (TCRS) signaling, as well as in signaling by the second-messenger nucleotide,
cyclic-di-GMP (18, 28, 116, 160, 174).

Cyclic-di-GMP and TCRS signaling in Borrelia spp.
Within the past several decades, the study of intracellular signaling by second
messenger nucleotides has come to the forefront of prokaryotic physiological research
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Figure 3. Ultrastructure and motility of Borrelia spp. A) The top portion shows an
entire view of the Borrelia spirochete. The outer membrane is shown in pink, the
periplasmic cylinder (including the inner membrane) is shown in yellow, and the
periplasmic flagella are shown, wrapping around the cylinder from both ends of the cell.
A view of the cellular structure is amplified in the bottom portion of the figure, where the
outer membrane, inner membrane, periplasmic space/flagella/peptidoglycan are shown.
B) Transmission electron micrograph showing 9 flagellar bundles wrapped in parallel
fashion around the periplasmic cylinder. Rotation against the cell cylinder is though to
generate torque to drive the spirochetes through host tissue. C) Graphical
representation of bi-polar cell rotation and movement. Cells gyrating in the same
direction (CW or CCW) causes a flex or pause, and cells gyrating in opposite directions
move in the direction of the pole moving CCW.
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A)

Adapted with permission from Rosa, PA et al. Nat Rev Microbiol. 2005
Feb;3(2):129-43.
B)

Adapted with permission from Charon, NW et al. J Bacteriol. 2009
Jan;191(2):600-7. Epub 2008 Nov 14.
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C)

Adapted with permission from Li, C et al. Proc Natl Acad Sci U S A. 2002
Apr 30;99(9):6169-74. Copyright (2002) National Academy of Sciences,
U.S.A.
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(15, 16, 176). Initial efforts focused on cyclic mononucleotides, however, in 1985, a
cyclic dinucleotide was identified in Gluconacetobacter xylinus that acted as an
allosteric activator of cellulose synthase (128, 129). The nucleotide was 3',5'-Cyclic
diguanylic acid (cyclic-di-GMP, or c-di-GMP), which was later realized to be a globally
distributed second messenger in the prokaryotic kingdom (69, 135). It was recognized
via bioinformatic analyses and later biochemical analyses, that c-di-GMP is produced
via proteins containing a GG(D/E)EF domain, named after the amino acid motif present
at the active site. Proteins with the GG(D/E)EF domain are also known as diguanylate
cyclases (DGCs), named after their ability to convert 2 molecules of guanosine-5'triphosphate (GTP) into c-di-GMP. DGCs are encoded for by almost all prokaryotic
genomes, including Gram-negative, Gram-positive, and spirochetal species (6, 60, 114,
135).
Down regulating the levels of c-di-GMP are phosphodiesteraes
(PDEs) containing EAL and HD-GYP domains (132, 146, 163, 166). EAL domaincontaining proteins and HD-GYP domain-containing proteins break c-di-GMP into
linear-di-GMP (l-di-GMP, pGpG) and GMP respectively. Like DGCs, most bacterial
genomes harbor multiple copies of EAL domains, though HD-GYP domains are more
rare (60, 133, 149). E. coli encodes for 29 DGCs and EAL PDEs and Vibrio spp.
encode for more than 50 DGCs and PDEs (69, 167). However, specific DGCs and
PDEs appear to have differential functions dependent upon differential gene expression,
temporal activity in response to environmental stimuli, and spatial separation of
signaling components, which allows for sequestration of specific c-di-GMP signaling
components (29, 65, 75, 113, 151). In other words, regulation of localized levels of c-di-
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GMP appears to be the driving force in the regulation phenotypes associated with the
second messenger.
Differential regulation has been demonstrated to be important in regulating c-diGMP signaling in E. coli via the DGCs YcdT and YdeH. Both proteins are
downregulated via the mRNA-binding protein CsrA, which inhibits poly-N-acetylglucosamine (PNAG) synthesis and stimulates expression of the flagellar regulator
FlhDC. This allows for the upregulation of the PDE YhjH, and subsequent transition
towards motile behavior (74, 75, 162). Temporal activity becomes important in the
cases of c-di-GMP signaling components that are part of TCRS. Several bacteria
encode for response regulators that synthesize c-di-GMP following phosphorylation by
their cognate histidine protein kinase (1, 28, 80, 85, 112, 135). Spatial separation of cdi-GMP signaling components has been documented in several bacterial species, but
most well studied is the example of PleD in Caulobacter crescentus. Following
phosphorylation of PleD by PleC or DivJ, PleD dimerizes and localizes at the cell pole.
This allows for localized production of c-di-GMP and is important in Caulobacter cell
cycle progression. In terms of most bacterial species, high levels of c-di-GMP correlate
with transition towards a non-motile and sessile state, biofilm formation,
exopolysaccharide (EPS) production, and expression of adhesive molecules which
allow for multicellular behaviors, important during certain infection phases (65, 113).
Low levels of c-di-GMP correlate with decreased biofilm formation and transition
towards a motile state. This has been observed in E. coli, S. enterica, and P.
aeruginosa (76, 91, 94, 115, 117, 134, 146).
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Because c-di-GMP does not act independently, it needs to be able to interact
with a number of different effector molecules, that in turn, translate levels of c-di-GMP
into physiological outcomes. Examples of c-di-GMP effector molecules include GEMM
RNA riboswitches, transcription factors, and PilZ domain-containing proteins (3, 37, 71,
83, 101, 117, 150, 158). C-di-GMP exerts its effects through interaction with GEMM
RNA riboswitches by interacting with the 5’ untranslated region (UTR). C-di-GMP
interaction with such molecules positively affects translation or stability of the RNA
molecule. For example, the Vc2 riboswitch (which resides upstream of a transcription
factor in V. cholerae), was shown to be an ‘on’ switch for protein translation when levels
of c-di-GMP are high (158). The interaction with transcription factors such as FleQ from
Psuedomonas aeruginosa, has been shown to regulate processes including EPS
production. FleQ acts to suppress proteins in the pel operon which is responsible for
EPS production. When c-di-GMP levels are elevated, this suppression is relieved and
the components of the pel operon are expressed (71). Finally, interaction with PilZ
domain-containing proteins, has been shown to affect various cellular processes,
including, but not limited to cell motility/flagellar function. This has been demonstrated
in V. cholerae, P. aeruginosa, and the Enterobacteriacae (41, 79, 88, 111, 117, 134).
The most notable and well-described mechanism is that of YcgR. YcgR of the
enterobacteria adopts a modulated structure upon binding to c-di-GMP, in turn,
increasing its ability to interact with the flagellar motor components FliG, FliM, and
MotA, causing a transition towards a sessile state (79, 111, 134). PilZ proteins have
also been demonstrated to control EPS production in organisms such as P. aeruginosa.
Alg44, and c-di-GMP binding by Alg44, was shown to be important in the biosynthesis

18

Figure 4. Cyclic-di-GMP signaling overview. C-di-GMP is produced from 2
molecules of GTP by diguanylate cyclases containing a GGDEF domain. Opposing cdi-GMP synthesis, are phosphodiesterases containing EAL or HD-GYP domains, which
cleave c-di-GMP into l-di-GMP or GMP respectively. Following synthesis, c-di-GMP can
interact with a number of effector molecules including proteins containing PilZ domains,
transcriptional regulators, or GEMM RNA riboswitches. Increased levels of C-di-GMP
have been shown to negatively influence motility and virulence and promote sessility
and biofilm formation in a number of organisms. They have also been shown to
positively affect cell cycle progression in Caulobacter cresentus.
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Adapted with permission from Hengge, R. Nat Rev Microbiol. 2009 Apr;7(4):263
73.

20

of alginate, an important Pseudomonas virulence factor (101). While these phenomena
have been marginally described in other bacteria, little is known about c-di-GMP signal
transduction in a spirochetal system. Figure 4 shows a basic diagram of c-di-GMP
signaling. Genomic analyses have indicated that the proteins involved in c-di-GMP
synthesis, breakdown, and effector functions are present within the genomes of the
spirochetal genera Leptospira, Tremponema, and Borrelia (57, 58, 80, 116, 125, 160).
In Borrelia spp., c-di-GMP signaling appears to be governed by one of its five
putative TCRS (28, 55, 80, 125). Because the Borrelia must rapidly adapt
physiologically to withstand different environments encountered within tick and
mammalian hosts, TCRS are a prime means to overcome such stresses and changes
(9). TCRS consist of a histidine protein kinase (Hpk) and a response regulatory protein
(Rrp). The Hpk is able to sense a specific environmental cue such as solute, oxygen
levels, and membrane stress – autophosphorylate itself, and transfer the phosphate
group to the Rrp. Following phosphorylation, the Rrp, can then carry out a specific
activity, which includes DNA-binding, RNA-binding, or an enzymatic activity (59, 61,
161). While three of the putative TCRS encoded for by the Borrelia genome appear to
govern processes in chemotaxis, two of these have global regulatory capability (24,
103, 109, 125). One with global regulatory capability is the Hpk2-Rrp2 TCRS. Hpk2
and Rrp2 predominantly govern gene regulation of plasmid carried genes. Interestingly,
most Hpks are found within the cytoplasmic membrane, but Hpk2 is predicted to be
cytosolic. Following phosphorylation/activation of Rrp2 by Hpk2 or acetyl phosphate
(AcP), it then acts in conjunction with the sigma factor, RpoN, to activate expression of
RpoS via DNA-binding, which governs expression of proteins such as OspC, DbpB/A,
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and BBK32 (fibrinogen-binding protein). Additionally, evidence suggests that Rrp2 may
act independently as an activator or repressor (17, 18, 67, 109, 172, 174).
The other TCRS encoded for by the Borrelia is the Hpk1-Rrp1 system. Different
from the Hpk2-Rrp2 system, is that Hpk1 is predicted to traverse the inner membrane,
but more importantly, Rrp1 lacks a DNA-binding domain and instead has a C-terminal
GGEEF domain. Following phosphorylation of Rrp1, the protein then enzymatically
synthesizes c-di-GMP from two molecules of GTP (28, 58, 80, 125, 135). Until recent
years, nothing was known about c-di-GMP signaling in bacteria of the genus Borrelia or
in any spirochetal system. Bioinformatic analyses demonstrated the presence of one
DGC (BB0419, or Rrp1), two c-di-GMP PDEs (EAL – BB0363, or PdeA; HD-GYP –
BB0374, or PdeB), and one PilZ domain-containing protein (BB0733, or PlzA) in B.
burgodorferi B31 (58, 125). However, certain strains of B. burgdorferi harbor a second
PilZ domain-containing protein (PlzB) encoded for on one of the linear plasmid 28 (lp28)
extrachromosomal genomic constituents. PlzB is 78% identical to PlzA, however, it is
unknown whether it functions similarly to PlzA (58, 80, 125).
In terms of this TCRS, it is interesting to note that rrp1 is located just downstream
of the gene encoding its cognate histidine protein kinase, Hpk1, and both are
cotranscribed. Rogers et al. spearheaded the study of c-di-GMP signaling in B.
burgdorferi by creating a deletion mutant of rrp1 in the non-infectious B. burgdorferi B31
derivative, 5A13. Microarray analyses demonstrated the importance of Rrp1 and, by
extension, c-di-GMP in the gene regulation of the Core Borrelia Genome, which
includes the chromosome, linear plasmid 54 (lp54) and circular plasmid 26 (cp26). The
genes regulated by Rrp1 constitute 10% of the genome, and include genes functioning
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in motility/chemotaxis, metabolism, nucleotide metabolism, transport, immune evasion,
and other cellular processes (125).
More recently, Kostick et al., created an rrp1 deletion mutant in the infectious B.
burgdorferi B31 derivative, 5A4, in order to assess its effects on motility, chemotaxis,
infectivity, and ability to complete the tick-mammal transmission cycle. Additionally,
these aspects of Borrelia biology were examined in an rrp1 overexpressing strain using
a pBRV2 expressed rrp1 under control of the flgB promoter. Deletion of rrp1 had
significant effects on motility and chemotaxis, as drastic decreases in swarming motility
and chemotaxis towards N-acetylglucosamine were observed. While the rrp1 deletion
mutant was still infective in mice, the rrp1 overexpressing strain was noninfective.
Spirochetes in the rrp1 deletion background were unable to colonize and survive in ticks
following immersion feeding, and as such, Ixodes ticks were unable to acquire
spirochetes from mammalian hosts (80). He et al. also demonstrated similar
phenotypes in an rrp1 deletion strain, both in terms of infectivity and in tick survival.
Interestingly, microarray analyses demonstrated a significant decrease in expression of
a four gene operon involved in glycerol transport and metabolism (BB0240-BB0243;
glp). Both the rrp1 and glp null strains demonstrated a significant growth defect in
glycerol-containing media (BSK-glycerol). Likewise, the glp deletion mutant was also
infectious, but had reduced survivability in ticks. When the glp operon was
overexpressed in the rrp1 deletion mutant, the growth defect in BSK-glycerol was
restored, and the ability to survive in ticks was also partially restored. Thus, it may be
that c-di-GMP governs a metabolic shunt in the tick environment (68).
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Similarly, a recent paper by Caimano et al., describes the deletion of hpk1 in two
infectious background strains of B. burgdorferi. Analyses of both mutants demonstrate
similar phenotypes to the rrp1 deletion mutant created by Kostick et al. and He et al.
Deletion of hk1 revealed a phenotype in which the mutants are able to fully infect
C3H/HeJ mice. Larval I. scapularis ticks are able to acquire spirochetes lacking hpk1
via feeding, but spirochetes were unable to survive within the tick midguts. This
phenotype may account for the lack of tick acquisition observed in the rrp1 deletion
mutant, which additionally provides supporting evidence for phosphorelay between
Hpk1 and Rrp1 (28).
Additionally, Sultan, et al., reported on the function of PdeA on B. burgdorferi
motility, infectivity, and the ability of the organism to survive in Ixodes scapularis ticks.
PdeA was shown to have a positive impact on motility, as the deletion of BB0363
caused a very slight decrease in motility. Additionally, its deletion eliminated the ability
of B. burgdorferi to successfully infect C3H/HeJ mice, as well as survive in ticks. Thus,
it appears as if elevated levels of c-di-GMP negatively impact these processes.
However, the discrepancy between similar phenotypes in rrp1 and pdeA deletion
mutants and their presumed differences in c-di-GMP levels, have not yet been
explained. PlzA has recently been investigated by Pitzer et al. and was shown to play
roles important in B. burgdorferi motility and virulence. Similarly to the rrp1 and pdeA
mutants, the plzA deletion mutant displayed a reduced swarming diameter, indicating
that the protein plays an important role in positively regulating Borrelia motility.
Additionally, the B. burgdorferi plzA deletion mutant displayed a reduced ability to infect
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mice as compared to wild type, in addition to a decreased ability to survive in fed ticks
(116).
Most recently, Sultan et al. published on PdeB of B. burgdorferi. PdeB was
shown to be an active HD-GYP domain-containing protein, and was shown to affect cell
motility, as a PdeB deletion mutant demonstrated increased flexing relative to the wild
type strain. The pdeB null strain was infectious in mice, but demonstrated reduced
viability in the tick vector – a phenotype seen in all B. burgdorferi c-di-GMP signaling
mutants (159). Phenotypes associated with c-di-GMP signaling in B. burgdorferi are
shown in Table 1. Based upon the present knowledge base of c-di-GMP signaling in
Borrelia spp., it is clear that c-di-GMP and the protein components involved in synthesis,
turnover, and effector functions are important in the biology of this species. However, a
marked amount of work remains to be performed in order to better understand each of
the components involved in Hpk1 signaling/phosphorelay, c-di-GMP production,
breakdown, and the effector mechanisms of c-di-GMP itself, through c-di-GMP-binding
proteins and potential undiscovered targets. The work here aims to demonstrate a
deeper understanding of c-di-GMP signaling through the study of PilZ domaincontaining proteins PlzA and PlzB, as well through a basic analysis of Rrp1 and PdeA in
the relapsing fever spirochetal species, B. hermsii strain DAH.

Research Objectives
Because c-di-GMP signaling is important in the Lyme spirochete, B. burgdorferi,
we wished to further characterize c-di-GMP signaling by the PilZ domain-containing
proteins PlzA and PlzB. Additionally, we wanted to characterize c-di-GMP signaling by
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Table 1. Published phenotypes of B. burgdorferi c-di-GMP signaling mutants
Swarming
Pattern of
Chemotaxis
Mouse
Tick
Motility

motility

Decreased

Run-pause-

infectivity

survival

N/D

(-)

(-)

N/D

(+)

(-)

Decreased

(+)

(-)

Strain
!BB0363
(5A3-PdeA)
!BB0374

no reverse
Normal

(5A3-PdeB)
!BB0419

Increased
flexing

Decreased

(5A4-Rrp1)

Runs,
infrequent
pauses

!BB0420

Normal

Normal

N/D

(+)

(-)

Decreased

Normal

N/D

(+/-)

(-)

(297-Hk1)
!BB0733
(5A3-PlzA)
References (28, 80, 116, 159,160)
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Rrp1 and PdeA of B. hermsii and the impacts of these proteins on motility and on
mammalian infectivity. In order to first assess the impact of PlzA, we desired to
examine the distribution of the plzA gene amongst the Lyme Borrelia, the basic
expression patterns of plzA during tick and mammalian infection, as well as the basic
biochemistry and analysis of c-di-GMP binding to PlzA. Next, we wished to examine the
effects of PlzA and PlzB on B. burgdorferi motility, chemotaxis, mammalian infection,
and ability of the spirochetes to complete the enzootic cycle between Ixodes ticks and
mammalian hosts. This was done by creating several mutants in a sequenced, wild
type strain B. burgdorferi B31 clone 5A4. The first mutant constructed is a plzA deletion
mutant. The other constructed mutants are allelic exchange derivatives in which plzB
replaces plzA in strain 5A4, which does not harbor a plasmid-encoded plzB gene.
These mutants were used to assess the above hypothesized functions of PlzA and
PlzB. Finally, we wished to assess c-di-GMP signaling in the tick-borne relapsing fever
spirochete, B. hermsii. Because B. hermsii causes such a drastically different disease
than Lyme disease, we desired to see if Rrp1 and PdeA have similar or different
functions compared to that of the Lyme disease Borrelia. The research carried forth
here not only strengthens our knowledge of c-di-GMP signaling in species of the genus
Borrelia and other spirochetes, but is also a step forward in techniques used for B.
hermsii genetic manipulation and phenotypic analysis, as well as our understanding of
c-di-GMP effector proteins in spirochetal species.
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Chapter 2: Materials and methods

Borrelia strains and cultivation
All B. burgdorferi, B. garinii, and B. afzelii isolates were cultivated in BSK-H
complete media containing 6% rabbit serum, and all B. hermsii isolates were cultivated
in BSK-H (Barbour-Stoenner-Kelly) complete media containing 12% rabbit serum.
Cultures were maintained at 25, 33, or 37°C within capped conical tubes stored in
humidified incubators under conditions of 5% CO2. All isolates used are listed within
Table 2. Spirochetes were selected in media containing streptomycin (200 µg/mL),
kanamycin (100 µg/mL), or gentamicin (40 µg/mL), as needed.

DNA isolation
Borrelia genomic DNA was isolated using a MasterPure DNA purification kit
(Epicentre). Cultures were harvested by centrifugation at 6,000 x g at 4°C for 15
minutes. Cells were washed in 1 mL PBS, collected again by centrifugation as
described above, and resuspended in 250 µL PBS and lysed by addition of 3 mL Tissue
and Cell Lysis Solution with 500 µg of proteinase K at 65°C for 20 minutes, and periodic
vortexing of samples every 5 minutes. The samples were placed at 37°C, and 50 µg of
RNase A was added and incubated with the lysed samples for 40 minutes. Following
RNase treatment, samples were cooled on ice for 10 minutes, 1.75 mL of MCP Protein
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Precipitation Reagent was added and the mixture was briefly vortexed for approximately
10 seconds. Cell debris was collected by centrifugation at 10,000 x g for 20 minutes,
the supernatant was placed in a clean 15 mL tube, and 5 mL isopropanol was added to
the supernatant. Tubes were inverted several times, and DNA was pelleted at 14,000 x
g at 4°C for 20 minutes. The collected pellets were rinsed twice with 75% ethanol and
resuspended in 50 µL water, and DNA concentration was determined using a UV
spectrophotometer.

Polymerase chain reaction (PCR)
PCR was performed using the PTC-100 Thermal Cycler from MJ Research, Inc.,
and the following cycle conditions were used: 1 cycle at 98°C for 2 minutes, and 35
cycles of 98°C for 20 seconds, 55°C for 15 seconds, 72°C for 1.5 minutes, and final
extension of 72°C for 4 minutes. Each PCR reaction contained 15 µL of 2x Phusion
buffer (containing proprietary buffer components and 3 mM MgCl2, 400 "M dNTP, and
Phusion polymerase), 13.55 µL MilliQ water, 0.23 µL of each primer (0.75 pmol/µL of
each primer) and 1 µL of DNA template (containing 1-10 ng genomic DNA or 0.1-1 ng
plasmid DNA). All primers are listed in Table 3 and were designed based upon
published genomic sequences of B. burgdorferi B31, B. burgdorferi ZS7, or B. hermsii
DAH. All DNA amplicons were analyzed by electrophoresis in 1% agaraose gels in
Tris-acetate-EDTA (TAE) buffered and visualized by staining with ethidium bromide.
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Table 2. Borrelia isolates used in this study
Species/Isolate
Geographic Origin
Source
________________________________________________________________
B. burgdorferi
64b

New York

Human

72a

New York

Human

80a

New York

Human

94a

New York

Human

118a

New York

Human

156a

New York

Human

20004

France

Ixodes ricinus

21343

Wisconsin

White-footed mouse

297

Connecticut

Human CSF

29805

Connecticut

Ixodes scapularis

3028

Texas

Human skin

5A3

New York

B31 derivative, infectious

5A4

New York

B31 derivative, infectious

B31

New York

Ixodes scapularis

Bol26

Italy

Ixodes ricinus

CA3

California

Ixodes pacificus

CA4

California

Ixodes pacificus

CA8

California

Ixodes pacificus

CA9

California

Ixodes pacificus

CA11.2a

California

Ixodes pacificus

CA12

California

Ixodes pacificus

CA-2-72

California

Ixodes pacfiicus

CA-2-87

California

Ixodes pacificus

FRED

Missouri

Human

LP4

Connecticut

Human skin

LP5

Connecticut

Human skin

LP7

Connecticut

Human skin
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MAC13

New York

Human skin

NY-1-86

New York

Human skin

R1000

United States

Ixodes scapularis

T2

United States

Ixodes scapularis

Veery

Connecticut

Veery bird

VS293

Switzerland

Ixodes scapularis

WI91-23

Wisconsin

Bird

ZS7

Germany

Ixodes ricinus

ACA-1

Sweden

Human skin

ECMI

Sweden

Human skin

IP21

Russia

Ixodes persulcatus

PKo

Germany

Human ACA

U01

Sweden

Human skin

UM01

Sweden

Human skin

VS461

Switzerland

Ixodes scapularis

Far04

Faeroe Islands

Puffin blood

FRG

Germany

Ixodes ricinus

G2

Germany

Human CSF

IP89

Russia

Ixodes persulcatus

PBi

Germany

Ixodes ricinus

PBr

Germany

Human CSF

Netherlands

Human skin

B. afzelii

B. garinii

B. spielmanii
A14S
B. valaisiana
VS116

Switzerland

Ixodes ricinus
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B. hermsii
DAH

E. Washington

Human blood

Tanzania

Human CSF

Ethiopia

Human blood

United States

Ornithodoros hermsi

Canada

Human periodontal pocket

B. duttoni
Ly
B. recurrentis
A1
B. turicatae
91E135
Treponema denticola
35405

CSF, cerebral spinal fluid; ACA, acrodermatitis atrophicans
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Table 3. Oligonucleotides used in this study
________________________________________________________________
Oligonucleotide
Sequence (5’ to 3’)
Primers for cloning of
recombinant proteins
Rrp1-pMAL-BamHIF

CGGATCCGTGGAAATGATAATTAAAGATAAA

Rrp1-pMAL-SalIR

CCCGTCGACTTAATATCTAAACTGATTTCTTCC

PlzA-pMAL-BamHIF

GGATCCTTGTTTAGTATTTTTATATTCAAAA
AAAGGAGAAAGGAGAGGT

PlzA-pMAL-SalIR

GTCGACTTAATTGAAATAATCATGGATCAAC
ATAGTATACTCAAGTGGTA

PlzA-R150DR154D-F

CCTGGGCAAAATCAGGATATTCATGAGGATAAT

PlzA-R150DR154D-R

ATTATCCTCATGAATATCCTGATTTTGCCCAGG

PlzA-R150KR154K-F

CCTGGGCAAAATCAGAAAATTCATGAGAAAAAT

PlzA-R150KR154K-R

ATTTTTCTCATGAATTTTCTGATTTTGCCCAGG

WspRpTyb12-BsmIF

GAATGCTATGCACAACCCTCATGAGAGCAAG

WspRpTyb12-EcoRIR

GAATTCTCAGCCCGCCGGGGCCGG

PlzB-pMAL-BamHIF

GGATCCATGGCAGTATCATCTAAAAAGATA
AGAGAGTATAGAAA

PlzB-pMAL-SalIR

GTCGACTCAGTCTTCAAAAAAATTAAAATAATT
ATGGATTATCATAGTATACTCAA

BHRrp1-pMAL-F

CGGATCCATGATGAAAGGTGTGAATTGG

BHRrp1-pMAL-R

CCAAGCTTTTAATATTTAAACTGATTTCGA

BHPdeA-pMAL-F

CATGAGGGATCCATAATAGAAGTAAATTT
AAAAG

BHPdeA-pMAL-R

CATGAGCTGCAGCTAATGGTGATGGTGATG
GTGAATAGGTTCTGGTTTATGCC
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Primers for construction
of allelic exchange vectors
BB0733USF

CATTTGATACAACTTGGTTTAAAACTG

BB0733USR

ACCGGTCTAGACGTCAGCTTCAAATTGTT
TTAAACAGTTTTAC

BB0733DSF

GACGTCTCAAAGGATTGAAATTTTTCT
TATGTGATTATG

BB0733DSR

ACCGGTCAGAATATATTCCCAAAAGTGCCC

BB0733KIF

GACGTCTTGTTTAGTATTTTTATATTCAAAA
AAAGGAGAAAG

BB0733KIR

TATCACCCCGGGTTAATTGAAATAATCA
TGGATCAACATAGTATACTC

BB0733USFPlzB

CATTTGATACAACTTGGTTTAAAACT

BB0733USRPlzB

TATCACACCGGTGACGTCAAACCTCTCCTTTCT
CCTTTTTTT G

pflgB-aphI-T7(BB0733)KIF

GTATACTATGTTTAGCCATGATTATTTCAATTAA
CTAATACCCGAGCTTCAAGG

pflgB-aphI-T7KIR

GACGTCCAGATCCGGATATAGTTCCTCCTTTC

plzBKIF

GACGTCATGGCAGTATCATCTAAAAAGATA
AGA GAG

plzBKIR

TATCACCCCGGGTCAGTCTTCAAAAAAATTAAA
ATAATTATGGATTATC

KanF

TATCACCCCGGGCTAATACCCGAGCTTCA
AGGAAGA

KanR

TATCACGACGTCTTAGAAAAACTCATCGAGCAT
CAAATGAAAC

BH0363USF

TATAAATTATCCTAGCTGGTTAC
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BH0363USR

ACCGGTGACGTCCTTATTTAAATAAATTTATA
TTAATTTTG

BH0363DSF

GACGTCAAATACACAAATGTTTTTTAATAC

BH0363DSR

ACCGGTACATACAGCGGTTTTGCTTGGTG

BH0419USF

ATAATGAAATTAATCAGAAG

BH0419USR

ACCGGTGACGTCTACTTCTCTATATTACTAGC
ATTC

BH0419DSF

GACGTCAGTTAAATTTTATAAGTTAAAG

BH0419DSR

ACCGGTTAGTGCTGATATTTTTACAG

BHpflgB-AacCR

AACATCGTTGCTGCTGCGTAACATATGAACA
CCCTCTATATCACAAATTGCTT

BHpflgB-AacCF

ATGTTACGCAGCAGCAACGATGTT

BHpflgB-F

TATCACGACGTCGTTAAAGAAAATTGAAATAAA
CTTGGACTATG

AacC-AatII-R

TATCACGACGTCTTAGGTGGCGGTACTTGG
GTC

BHKanRAatII-R

TATCACGACGTCTTAGAAAAACTCATCGAGC
ATCAAATGAAAC

GentGFP-F

AGTGATGCACTTTGATATCGACCCAAGTAC
CGCCACCTAAGGGCGAATTCGGCT

GentGFP-R

TTAATCTTTAGTTAGTTAGGGAATAAGCCGAAT
TCGCCCTTAGGTGGCGGTACTTGGGTC

GFP-AatII-R

GACGTCCTATTTGTATAGTTC

KanGFPBH0363

GACAAGGATTCCTATGGCATAAACCAGAAC
CTATTTAAGCTAGCGTTGATCTTATAAATC

BH0363OLR

GATTTTACATCAGTTTGATTTATAAGATCA
ACGCTAGCTTAAATAGGTTCTGGTTTATGC

BH0363F

GTACATGACGTCATGAAAAATCCAAATGCA
ATTG
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KanGFPBH0419

AAGCTAAGATTTCTGGTCGAAATCAGTTTAAAT
ATTAAGCTAGCGTTGATCTTA

BH0419OLR

ATTTTACATCAGTTTGATTTATAAGATCAACGC
TAGCTTAATATTTAAACTGATTTCGAC

BH0419F

GTACATGACGTCATGATGAAAGGTGTGATT
TTG

Primers for screening
of allelic exchange
mutants
BBA16F

GCACAAAAAGGTGCTGAG

BBA16R

CACTTGCTGATCCTTCAG

BBB19F

AATAATTCAGGGAAAGATGGG

BBB19R

AGGTTTTTTTGGACTTTCTGCC

BBC10F

GAACTATTTATAATAAAAAGGAGAGC

BBC10R

ATCTTCTTCAAGATATTTTATTATAC

BBD21F

CTACCTTAAGCGGAAATATTGC

BBD21R

GAATAATTCTTCGCTCCCAAAGCTC

BBE16F

ATGGGTAAAATATTATTTTTTGGG

BBE16R

AAGATTGTATTTTGGCAAAAAATTTTC

BBF20F

ATGAACAAAAAATTTTCTATTTC

BBF20R

GTTGCTTTTGCAATATGAATAGG

BBG02F

TCCCTAGTTCTAGTATCTACTAGACCG

BBG02R

TTTTTTTTGTATGCCAATTGTATAATG

BBH28F

GGCTTCAATTAAGGGAGGAG

BBH28R

CACAATATAATCCGCAACATTC
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BBI26F

GCAAGGACTTTGCCACATGCTG

BBI26R

CGAAATAGCACATAGATAATTCC

BBJ34F

AAATTCTATGGAAGTGATG

BBJ34R

CGAAATAGCACATAGATAATTCC

BBK19F

AAGTTTATGTTTATTATTCG

BBK19R

ATTGTTAGGTTTTTCTTTTCC

BBL32/33F

GAAGATTTAAACAAAAAAATTGCG

BBL32/33R

GTAATCACTTCTTTTTTACCATCG

BBM32F

GACTTTACATAGTATAAATGCTTTTGG

BBM32R

TCTCGTTATTATAAAATAAGTAGG

BBN32/33F

TATCAAAAAAGTGCTGTTTTATAG

BBN32/33R

TAATCTCAAATATTCTTCTTTATG

BBO32F

GGAATGTATTAATTGATAATTCAG

BBO32R

GCGAAATAAATAGTGCCTTATGGG

BBP33F

ACGATAGGGTAATATCAAAAAAGG

BBP33R

AGTTCATCTAATAAAAATCCCGTG

BBQ47F

AAGATTGATGCAACTGGTAAAG

BBQ47R

CTGACTGTAACTGATGTATCC

BBR33F

AGATCCTCAAAATAGTTTAACCAG

BBR33R

TTAATATTGGCAGAGAGTCTACAG

BBS53F

TTACGAAAAAATAGAAAAACTAGG

BBS35R

TTTCCACTGCCCACTTTTCAGCCG

LP5F

CTTGCTTTAAGCCCTATTTCAC
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LP5R

GCACACTACCCATTTTTGAATC

BBU21F

AGTAAAGGAGTTCTGCAAAAATT

BBU21R

GTTGTCACCTCGTGTAATATG

BB0733>1000US

CCCAATAAATCTGATATCGCATCACT

BB0733>1000DS

CCTTTAATAGTACATGTTGATACGG

Spec5’R

TCCTTGAAGCTCGGGTATTA

Spec3’F

GGCGAGATCACCAAGGTAGTC

Kan5’R

GTTTAAAAATTTTTTTCAAATCGTCTA

Kan3’F

ATCAGAATTGGTTAATTGGTTGTAACA

PlzBR

CTCAAGCGGGATATTACTCTCATC

BH0363>1000US

TTAAGGAAACAAAACATGATG

BH0363>1000DS

TATGTCTGATACGAAATATTC

BH0419>1000US

TCTGATTGGATTAGAAATGG

BH0419>1000DS

GAAAATCTAACACTAGACATGC

Gent5’R

GTAACATCGTTGCTGCTGCG

GFP3’F

CATGGCATGGATGAACTATACAAATAG

Primers for RT
and qPCR
Rrp1-QF

CGGGATCGCTTTTTAGCTTT

Rrp1-QR

TTGAGGTTGCAACAAATGGA

PlzA-QF

CTTTTGATTATGGGGATGTCG

PlzA-QR

AAAGCAATACCAAGCGCAAA

FlaB-QF

GCTCCTTCCTGTTGAACACC
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FlaB-QR

TTCATGTTGGAGCAAACCAA

FlaB-QF(Tick)

GCAGCTAATGTTGCAAATCTTTTC

FlaB-QR(Tick)

TGAGCTCCTTCCTGTTGA

BB0733F-RT

CTGATAAAGCTTTTATCAAGTTTAATGGAG

BB0733R-RT

AGCGCAAAAACCTTTCCGCT

BBU_ZS7F20F-RT

TAGTATACTCAAGCGGGATATTACTC

BBU_ZS7F20R-RT

GGAATCCTTGATGAAGACATGG

BB0337F-RT

GCTTGAACTTGATGGCACCCCTAC

BB0337R-RT

GTACGCTCCAAGATATTGATAAGG

BH0363F-RT

AACAACATCAGCGAATTAAGCGA

BH0363R-RT

TGGGAGTTCAAGTTCTTTGCTGCC

BH0419F-RT

AACTCCTCACCACCATAACGAGCA

BH0419R-RT

TCTTGGATGCAAGCCTTGGAGCAT

BH0337F-RT

TGCTTGCACTTGACGGAACTCCTA

BH0337R-RT

GTGGGCGCCGCCATTTATATTGTT
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Site-directed mutagenesis
Site directed mutagenesis was conducted using a PCR approach. Firstly,
mutagenic primers were designed that contained in-frame codon mutations for the
purpose of generating mutant recombinant proteins. The gene of interest (plzA) was
then amplified as two different amplicons. For the 5’ end of plzA was amplified using a
forward primer with specific restriction sites and a reverse primer which contained the
desired in-frame sequence changes. The 3’ end of the gene was amplified using a
reverse primer (again with specific restriction sites for use in downstream cloning), and
the forward primer contained the desired mutated sequence. Amplicons were produced
via PCR and purified using the QIAquick Gel Extraction Kit (Qiagen) following
electrophoretic analysis of the products. Following purification of both products, a
second round of PCR was performed using both the 5’ and 3’ end products. Both
mutagenic primers overlapped, in order for complementary annealing to occur during
the second round of PCR, such that the desired changes could be introduced. The
resulting amplicons were purified using the QIAquick Gel Extraction kit and were cloned
into pCR2.1-TOPO as described below. Plasmid inserts were sequenced to verify the
intended changes.

TOPO-TA Cloning
For the generation of vectors used in recombinant protein expression, as well as
the generation of vectors used in allelic exchange mutagenesis, TOPO-TA cloning was
performed. PCR products were amplified, analyzed by gel electrophoresis, and purified
using the QIAquick Gel Extraction kit (Qiagen). Four µL of the PCR product was
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aliquoted into a separate tube, 1 µL of the provided Salt Solution (Invitrogen) was
added, and lastly, 1 µL of pCR2.1-TOPO (Invitrogen) was added. The tube was
incubated at room temperature for 5 minutes, and 1 µL was used to transform the
provided One Shot® E. coli TOP10 cells (Invitrogen). Cells were transformed by adding
1 µL of the TOPO-TA reaction to the prealiquoted cells (20 µL). Cells were incubated
on ice for 5 minutes, heat shocked at 42°C for 30 seconds, placed back on ice for 2
minutes, and 80 µL SOC media was added to the cells. This was the transformation
protocol used for all cell types and vectors/vector reactions. Cells were incubated at
37°C for 1 hour, and plated onto solid Luria-Bertoni (LB) plates containing ampicillin
(Amp) at 50 µg/mL and bromo-chloro-indolyl-galactopyranoside (X-gal; 40 µL of 40
mg/mL spread on top of the plate). Plates were incubated at 37°C overnight and the
resulting colonies were screened by blue/white screening and PCR. Positive colonies
were grown overnight at 37°C, and vectors were harvested using the QIAprep Spin
Miniprep Kit (Qiagen).

Cloning of plzA, plzB, rrp1, and wspR for protein expression
Vector pCR2.1-TOPO containing plzA, mutant plzA, plzB, or rrp1 contained a
BamHI restriction site 5’ to the open reading frame and a SalI restriction site 5’ to the
open reading frame. pCR2.1-TOPO vectors and the pMAL-c4x expression vector (New
England Biolabs) were digested with BamHI and SalI (New England Biolabs) for 60
minutes at 37°C. Additionally, pMAL-c4x was treated with calf intestine alkaline
phosphatase (CIP, New England Biolabs) for an additional 60 minutes at 37°C. Proper
excision of the genes from pCR2.1-TOPO and proper linearization of pMAL-c4x was
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analyzed by the use of agarose gel electrophoresis and ethidium bromide staining. The
excised gene products and linearized pMAL-c4x were purified using the QIAquick Gel
Extraction kit (Qiagen). Inserts were ligated into pMAL-c4x using T4 DNA Ligase (New
England Biolabs) and ligated vector was transformed into NovaBlue E. coli cells.
Positive colonies were selected by PCR and propagated overnight as described above.
Vector was purified using the QIAprep Spin Miniprep Kit (Qiagen) and transformed into
BL21(DE3) E. coli cells for protein expression. Likewise, wspR (originally amplified from
P. aeruginosa strain FRD-1, kindly provided by Dr. Dennis E. Ohman) was excised from
pCR2.1-TOPO using BsmI and EcoRI and ligated into vector pTYB12 (New England
Biolabs). The resulting vector was transformed into E. coli ER2566 for protein
expression.

Recombinant protein expression and purification
To generate r-proteins from pMAL-c4x, BL21(DE3) E. coli was grown with
shaking (250 rpm) at 37°C in LB broth containing 50 µg/mL Amp for approximately 2.5
hours, until on OD600 of 0.5-0.8 was reached. Cells were shifted to 25°C and IPTG was
added to a final concentration of 1 mM. Protein expression was allowed to proceed for
3 hours, at which time, cells were harvested by centrifugation (6,000 x g, 4°C, 10
minutes). Harvested cells were lysed by sonication, and supernatants were collected
via centrifugation (15,000 x g, 4°C, 20 minutes). Supernatant was passed over amylose
resin (New England Biolabs) to allow binding of the N-terminal mannose-binding protein
(MBP) to the amylose, washed in PBS (MBP-PlzA and MBP-PlzB) or diguanylate
cyclase reaction buffer (Tris (pH 7.8), 250 mM NaCl, 25 mM KCl, 10 mM MgCl2) in the
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case of MBP-Rrp1. Proteins were eluted in the appropriate buffer containing 10 mM
maltose and stored at 4°C for further use.
WspR was expressed in E. coli ER2566 by growing the cells at 37°C to an OD600
of 0.3 and was induced with 0.3 mM IPTG at 18°C overnight. Cells were collected by
centrifugation as described above, lysed by sonication and protein was purified using
chitin affinity chromatography. Intein cleavage by dithiothreitol (DTT, 50 mM) was
allowed to proceed for 48 hours at 4°C, and protein was eluted with reaction buffer (75
mM Tris, pH 7.8, 250 mM NaCl, 25 mM KCl, 10mM MgCl2). Protein was dialyzed over
diguanylate cyclase reaction buffer containing 40% glycerol and was also stored at 4°C
for further use.

Expression and purification of r-PdeA (BH0363)
pdeA (amino acids 386-663) was amplified by PCR and cloned into pMAL-c4x
(New England Biolabs) using restriction sites engineered into cloning primers (Table 3).
Additionally, BH0363 was tagged C-terminally with sequence encoding for a 6xHis tag
by including sequence encoding for the His tag in the antisense primer. Protein
expression from E. coli BL21(DE3) was carried out as described above. Cells were
lysed by sonication, soluble fractions were collected by centrifugation, and recombinant
protein was purified using nickel affinity chromatography using a Ni-NTA column (GE
Life Sciences) on an AKTApurifier (GE Life Sciences). Protein purification was
confirmed by staining with Coomassie and by western blotting. Protein was dialyzed
overnight in PDE buffer (75 mM Tris pH 8.0, 250 mM NaCl, 25 mM KCl, 10 mM MgCl2,
30% glycerol) and concentrations were determined using the BCA assay (Pierce).
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Synthesis of c-di-GMP and [32P]c-di-GMP
r-WspR and r-Rrp1 were used to generate radiolabeled and cold c-di-GMP. The
r-Rrp1 (both B. burgdorferi and B. hermsii Rrp1) and r-WspR (5 mM) were incubated
with 25 mM acetyl phosphate (37°C for 30 minutes) to potentially activate the proteins.
To generate cold c-di-GMP, GTP was added to each reaction at a final concentration of
150 mM (37°C; 60 minutes). To generate radiolabeled c-di-GMP, the reactions were
spiked with [#-32P]GTP (0.33 mM). The production and purity of the c-di-GMP was
assessed using HPLC. GTP (Sigma-Aldrich) and unlabeled c-di-GMP (Biolog) served
as standards. HPLC was performed essentially as described by Ryjenkov et al. (132).
Briefly, the samples were boiled, filtered (Ultrafree centrifugal filters; Millipore), applied
to a 15 x 4.6 cm Supelcosil LC-18-T column (Supelco) and separated on an
AKTApurifier (GE Health Sciences) by reverse-phase HPLC. The gradient system
utilized buffers A (100 mM KH2PO4, 4 mM tetrabutyl ammonium hydrogen sulfate, pH
5.9) and B (75% buffer A, 25% methanol). The protocol utilized is as follows (in the
format of minutes transpired; % buffer B): 0.0, 0; 2.5, 0; 5.0, 30; 10.0, 60; 14.0, 100;
21.0, 100; 22.0, 50; and 23.0, 0 at a flow rate of 700 µL/minute. Nucleotides were
detected at a wavelength of 254 nm.

PdeA phosphodiesterase assays
Phosphodiesterase assays were carried out essentially as described by Sultan,
et al (160, 163). Radiolabeled c-di-GMP was synthesized using B. hermsii Rrp1 as
described above, and was subsequently treated with 1 unit of calf intestine alkaline
phosphatase (CIP; New England Biolabs) to hydrolyze any remaining GTP. Reactions
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were boiled for 3 minutes, and filtered through Ultrafree centrifugal filters (Millipore).
The resulting [32P]c-di-GMP (~6 nM) was added to 2 µg of PdeA (in the presence or
absence of 50 mM MnCl2). Snake venome phosphodiesterase (SVPD; 0.3 units)
served as a positive control, and r-PlzA served as a negative control. Reactions were
carried out for 1 hour at room temperature, and time points were taken at 0, 15, 30, 45,
and 60 minutes. Reactions were stopped by spotting 0.5 µL onto PEI-cellulose plates
(Selecto). Plates were developed in 1:1.5 (v/v) 4M H4SO4 and 1.5 M KH2PO4, pH 3.60,
air-dried, and exposed to X-ray film overnight at room temperature.

Analysis of c-di-GMP binding to wild type and site-directed substitution mutants
of PlzA and PlzB
r-PlzA, site-directed substitution mutants (R150D,R154D and R150K,R154K), rPlzB and control proteins were tested for c-di-GMP binding. The r-proteins (0.25 mg)
(including Rrp1 and a MBP-tagged negative control protein) were spotted onto
nitrocellulose and allowed to air dry. The membranes were incubated with [32P]c-diGMP (2 nM) alone, or in combination with 750 nM of GTP, GMP, ATP, cGMP, or cAMP
(PBS with 1% milk; 2h; room temperature). The membranes were washed three times
for 5 min in PBS at room temperature and exposed to film overnight.

Preparation and analysis of B. burgdorferi/B. hermsii RNA from cultures and from
I. scapularis ticks infected with B. burgdorferi
To assess expression of genes from in vitro cultures, RNA was isolated from
Borrelia cultures using the RNeasy Midi kit as described by the manufacturer (Qiagen)
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and treated with DNase I (Invitrogen). cDNA was generated using the Superscript III
First Strand cDNA Synthesis kit (Invitrogen), 50 ng of random hexamer primers and 1
µg of total RNA. RT-PCR was performed with SYBR green PCR Master Mix (Applied
Biosystems) with primers listed in Table 3. The following cycle parameters were used:
one cycle of 10 min at 95°C followed by 40 cycles of 10 s at 94°C, 30 s at 50°C and 30
s at 72°C. Melting curves were generated over the temperature range 45–95°C to
assess amplification specificity. All reactions were run in triplicate with three biological
replicates and the data were normalized against enolase (eno). Statistical analyses
were performed using a paired, two-tailed t-test. Alterations of gene expression were
considered significant if P < 0.05.
To allow for the analysis of specific B. burgdorferi transcript levels in Ixodes
scapularis ticks, it was first necessary to infect mice so that naïve ticks could be infected
by natural feeding. Mice (C3H/HeJ; Jackson labs) were inoculated with B. burgdorferi
B31 5A4 (104 cells; subcutaneous) and infection was confirmed by culture of ear
biopsies and by serology. The naïve larval ticks, provided by Dr. Durland Fish (Yale
University), were placed on infected mice (150–200 per mouse) and fed to repletion
(48–96 h). The ticks were collected and maintained for 8-10 weeks in desiccator
chambers (21°C; 100% humidity) until molting to the nymphal stage. Two weeks postmolt, pools of 100 infected flat nymphs were used for RNA isolation. The remaining
infected flat nymphs (~30) were placed on naïve, uninfected C3H/HeJ mice and fed to
repletion. All mice became infected as confirmed by culture positivity of ear tissues. To
isolate RNA, 100 flat nymphs or 30 fed nymphs were crushed in glass homogenizers
containing 1mL of TRizol reagent (Invitrogen) and debris was removed by centrifugation
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(300 x g). Supernatants were used for RNA isolation according to the manufacturer’s
instructions (Invitrogen). To remove contaminating genomic DNA, RNA samples were
treated twice with RNAse-free DNAse using the Ambion DNA free kit.

Preparation of RNA from the organs and tissues of mice infected with B.
burgdorferi
Mice were infected as described above with B. burgdorferi B31-5A4 (a clonal
derivative of B31 kindly provided by Jon Skare, Texas A&M). Note that for logistical
reasons a separate pool of mice were used for these analyses than those described
above. Mice were sacrificed at 2, 4, 6 and 13 weeks (five mice per time point) and the
urinary bladders were collected and prepared for RNA analyses. RNA was isolated as
described previously (125).

Real-time quantitative reverse transcriptase-PCR (qRT-PCR) of RNA isolated from
animal tissue
Total RNA isolated from ticks or from urinary bladders of infected mice was
reverse transcribed using 10U AMV reverse transcriptase and random hexamers as
described by the supplier (Promega). The cDNA was used as template for qPCR with
gene-specific primers (designed using PRIMER EXPRESS software, version 2.0;
Applied Biosystems) as described previously (124, 125). All primers are listed in Table
3. Duplicate or triplicate assays were carried out with each RNA sample and were
performed with RNA obtained from two separate pools of flat nymphs, three separate
pools of fed nymphs or with RNA from murine bladders. qPCR data were normalized

47

against flaB transcript levels. To verify the purity of the PCR product, melting curve
analyses were performed and a no-template negative reaction control was included.
The statistical significance of observed expression differences between flat and fed
nymphs was evaluated by an unpaired t-test with two-tailed P-values and 95%
confidence interval using GRAPHPAD PRISM software (v 5.0) (La Jolla, CA).

Allelic exchange mutagenesis
Allelic exchange mutagenesis was carried out using protocols first described by
Samuels et al (137). In brief, separate PCR reactions were prepared to amplify the
upstream and downstream regions of plzA (1000 bp on each side), and the resulting
products were cloned into pCR2.1-TOPO. The primers used to generate pCR2.1upstream and pCR2.1-downstream contained restriction sites to facilitate the following
cloning steps (Table 3). pCR2.1-upstream and pCR2.1-downstream were digested with
AatII and AgeI, and the excised fragment from pCR2.1-downstream was ligated into
pCR2.1-upstream to create pCR2.1-up/down. Next, to generate the vector for deletion
of plzA, we excised the spectinomycin/streptomycin resistance cassette derived from
pKFSSl-AatII and it was inserted in between the up and downstream fragments at an
AatII site to generate p!plzA. To create the vector used for generation of our
complementation mutant, we carried out overlap-extension PCR to fuse plzA with a
kanamycin resistance cassette derived from pBSV2. This product was cloned into the
AatII site in the pCR2.1-up/down vector to create pplzA-KI. Next PCR was carried out
to amplify BbuCA12plzB and pflgB-kanR in which the sense primer contained an XmaI
site and anti-sense primer contained an AatII restriction site for downstream cloning.
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The resulting PCR products were cloned into pCR2.1-TOPO, and digested with XmaI
and AatII, which was also used to digest pCR2.1-up/down. The excised band was
ligated into pCR2.1-up/down to create pplzB-KI. p!plzA, pplzA-KI, and pplzB-KI were
propagated in NovaBlue E. coli (Invitrogen), purified, linearized with ScaI, and
electroporated into B. burgdorferi clone 5A4. Clonal populations were obtained by
subsurface plating and plasmid content was assessed by PCR using plasmid specific
primers. The resulting clones were screened by PCR for correct insertion, and mutants
were sequenced to ensure proper crossover.
To generate vectors for deletion and complementation of pdeA and rrp1 of B.
hermsii DAH, identical strategies were utilized. In brief, 1000 base pairs upstream and
1000 base pairs downstream of the coding regions of BH0363 and BH0419 were PCR
amplified. The resulting products were cloned into pCR2.1-TOPO vector (Invitrogen).
The plasmids containing the downstream fragments were purified, digested (AatII/AgeI),
and ligated into pre-digested plasmid (AatII/AgeI) containing the upstream fragments.
This created 2 plasmids that contain the 1000 bps upstream and downstream of
BH0363 and BH0419, separated by an AatII site. The pflgB-kanR-gfp cassette was
used to create a pflgB::gentR-gfp flanked by AatII sites. The AatII containing amplicon
was digested with AatII and ligated into the pCR2.1-up/down plasmids, creating the
deletion vectors (p!BH0363 and p!BH0419). Complementation vectors were created
using overlap-extension PCR to fuse the pflgB::kanR-gfp cassette to the coding regions
for both BH0363 and BH0419. This method produced AatII flanked regions that contain
the respective coding sequence followed by pflgB::kanR-gfp. The resulting fragments
were cloned into pCR2.1 TOPO vector (Invitrogen). Subsequent AatII digestion and
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ligation into the pCR2.1-up/down vectors created the complementation vectors
(pBH0363-KI and pBH0419-KI). The resulting plasmids were propagated in NovaBlue
E. coli (Invitrogen), purified, linearized with ScaI, and electroporated into B. hermsii DAH
to create the BhDAH!rrp1 and BhDAH!pdeA deletion strains, and the
BhDAHrrp1::kanR and BhDAHpdeA::kanR complementation strains.
B. hermsii electroporation was carried out as described in Fine, et al (53).
Limiting dilutions were used to obtain clonal B. hermsii cultures as described in
Hofmeister et al. (72). In brief, the dilutions were carried out in 96 ELISA plates, which
were covered to prevent BSK-H evaporation. Growth was assessed at 5, 10 and 15
days post-dilution. Potential positive clones were inoculated into fresh media and
confirmed later by change in the media indicator from red to yellow.

Pulsed-field gel electrophoresis (PFGE)
For analysis of B. hermsii plasmid content following electroporation, PFGE was
performed. First, plugs were generated by pelleting 2x108 bacterial cells via
centrifugation (6,000 x g, 15 minutes, 4ºC), and resuspending the pellet in 500 µLof TN
buffer (50 mM Tris HCI pH 8.0,150 mM NaCl). The suspension was mixed with an
equal volume of 1.4% low melting temperature InCert agarose (Lonza) at 50ºC. The
resulting mixture was transferred to a plug caster for solidification. Plugs were treated
overnight with proteinase K (1 mg/mL) at 45ºC in 50 mM Tris HCI pH 8.0, 50 mM EDTA,
1.5% SDS. Plugs were inserted into a 1% pulsed-field gel (Seakem Gold; Lonza) made
with 0.5x Tris-boric acid-EDTA buffer (TBE), sealed with 0.7% low melting point
agarose, and full genomic content was separated using a BioRad contour-clamped
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homogenous electric field (CHEF) mapper system in 0.5 x TBE. Plasmid content was
analyzed following staining in ethidium bromide by visualization on a UV light box.

Mutant growth rate analysis.
Growth rates of Borrelia stains were assessed by inoculation of BSK-H with
equal numbers of early log phase spirochetes (1 spirochete/40x field). The cultures
were grown at 25, 33, and 37ºC. Cells were enumerated daily until they reached their
respective maximum densities, as determined by dark-field microscopy. Each day, 10
fields of 40x magnification were used to determine the average spirochetes per field.
Assays were performed in triplicate.

Motility analysis
Motility in BSK-H complete media with 1% methylcellulose was examined using
differential interference contrast (DIC) microscopy. Movies of spirochetes were
recording using time-lapse photography and were analyzed using Slidebook 5 motiontracking software (Intelligent Imaging Innovations). Measurements of velocity were
calculated using 20 motion-course tracks per strain. Microscopy was performed at the
Virginia Commonwealth University Department of Anatomy and Neurobiology Core
Microscopy Facility.

Swarming motility analysis assays
Swarming motility assays were carried out as described in Motaleb et al. (102).
Briefly, 5x105 spirochetes in 5 µL of a 1:10 dilution of BSK-H in dPBS were pipetted onto
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agarose plates containing 0.35% (wt/vol) Seakem GTG agarose in BSK-H. The plates
were incubated at 33ºC (B. burgdorferi mutants) or 37ºC (B. hermsii mutants). Swarm
diameters were measured at 2, 4, and 6 days using electronic calipers. Assays were
performed in triplicate and representative swarms were photographed at each time
point.

Capillary chemotaxis assays
Capillary chemotaxis assays were performed using a modified version of the
protocol from Motaleb, et al (90). In brief, cells were harvested by centrifugation and
resuspended in motility buffer containing 1% (wt/vol) BSA and 1% (wt/vol)
methylcellulose at 107 cells/ml. The cells were then aliquoted into the wells of a 96 well
plate. Capillary tubes were filled with motility buffer with or without chemoattractant (0.1
M N-acetyl-D-glucosamine) and were capped at one end with Critoseal (Leica). The
open ends of the capillary tubes were inserted into the wells and the plates were
incubated at 37º for 2h. Following the incubation, the contents of the capillary tubes
were expelled into microcentrifuge tubes, and dark-field microscopy was used to
determine the number of spirochetes per field. Assays were performed in triplicate.

Lyme disease model of murine infection
Numbers of B. burgdorferi 5A4 and mutant strains were enumerated by counting
ten 40x fields via dark-field microscopy. Cells were pelleted by centrifugation (6,000 x
g, 15 minutes, 4°C), and resuspended in BSK-H such that the final volume contained
1x104 cells/100 µL. C3H/HeJ (Jackson Laboratories) mice were injected with1x104 cells
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subcutaneously. Infection was allowed to proceed for 4 weeks at which time serum was
collected, mice were sacrificed, and the heart, ear, and urinary bladders were harvested
to assess outgrowth of spirochetes in BSK-H growth media containing 1x Borrelia
Antibiotic Cocktail (20 "g/ml phosphomycin, 50 "g/ml rifampicin and 2.5 "g/ml
amphotericin B) (Sigma Aldrich). Outgrowth was assessed at 2 and 4 weeks postsacrifice. Serum was used for western blots and ELISA assays to assess
seroconversion as described below.

Tick studies
Ixodes scapularis ticks (naïve larval-stage; Oklahoma State University Tick
Rearing Facility) were brushed onto mice 4 weeks post-inoculation with the B.
burgdorferi strains described above and used in these studies. Ticks were fed until
repletion, were collected, and DNA was isolated using the DNeasy Blood and Tissue kit
(Qiagen). qPCR was performed using a B. burgdorferi flaB specific primers and data
was normalized versus tick rDNA using RIB-3 and RIB-4 primers. To assess strain
survival in larval ticks, naïve I. scapularis ticks were submerged in B. burgdorferi
cultures (108 cells/mL; 33°C; 2 h), washed, allowed to dry for one week and then fed to
repletion on naïve mice. One week after the ticks dropped off, DNA was isolated and
analyzed by qPCR as described above.

Relapsing fever model of murine infection
Infectivity of the various B. hermsii strains was assessed by dark field microscopy
of blood collected from infected C3H/HeJ mice, and seroconversion analysis by western
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blot and ELISA. Mice (n=3) were subcutaneously needle inoculated between the
shoulder blades with 1x104 spirochetes in BSK-H as described for B. burgdorferi and
mutants. A single microliter of blood was collected by tail snip from the mice at day 3
post-infection and for 12 days thereafter. Blood was diluted 1:20 in PBS each day, and
cells were enumerated via the counting of ten 40x fields by darkfield microscopy. Total
numbers of spirochetes/mL was calculated and plotted over a time course to show
levels of spirochetemia.

Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and
immunoblotting (western blotting)
To assess expression of r-proteins, purification of r-proteins, and to separate
Borrelia whole cell lysates, SDS-PAGE was performed. In brief, samples were
separated on 15% Criterion Precast Gels (Bio-Rad) by SDS-PAGE, and blotted onto
polyvinylidene difluoride (PVDF) membranes (Millipore). Expression and purification of
recombinant proteins was assessed using polyclonal rabbit anti-MBP IgG (1:2,000; New
England Biolabs) which recognizes all r-proteins used in these studies (with the
exception of WspR, in which expression was analyzed using staining with Coomassie
R-250, and subsequent destaining). Detection of bound antibody was performed using
goat anti-rabbit IgG-horseradish peroxidase (HRP) conjugated antibody (1:40,000).
In order to assess seroconversion of mice infected with B. burgdorferi 5A4 and
mutants and B. hermsii DAH and mutants, Borrelia whole cell lysates blotted onto PVDF
were screened with antisera at a 1:1,000 dilution. Secondary detection was achieved
using HRP-conjugated goat anti-mouse IgG. Dilution was performed in 5% milk in PBS-
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T (1x PBS, 0.2% Tween-20). Washes in PBS-T were performed between all detection
steps, and detection was achieved using chemiluminescent substrate (Super Signal
West Pico; Pierce) and exposure to X-ray film.

ELISA and seroconversion
To assess seroconversion by ELISA, Borrelia cells at a concentration of
OD600=0.1 per 100 µL of carbonate buffer (pH 9.6; overnight; 4°C) were coated onto to
well surface of 96 well plates. Plates were subsequently blocked with 1% BSA in PBST and serial dilutions of antiserum were performed, beginning at 1:50 and following with
subsequent 1:3 dilutions of each concentration. Plates were incubated for 1 hour at
room temperature with shaking during all screening steps. Plates were washed three
times using a plate washer, and bound IgG was detected using peroxidase-conjugated
goat-anti-mouse IgG antiserum (1:20,000). Following subsequent washes, ABTS
chromagen was added, incubated for 10 minutes at room temperature, and plates were
read at a wavelength of 405 nm. Measurements from duplicate samples were
averaged, plotted on a log10 scale, and titers were determined using a 50% maximum
cut-off. Infection was defined as a log IgG titer greater than 2.0.

Determination of intracellular c-di-GMP concentration
B. hermsii cultures grown in BSK-H complete medium at 37°C (50 mL), were
collected by centrifugation, and resuspended in 0.35 mL 0.4 M ice-cold HClO4. Cells
were lysed by sonication and centrifuged at 16,000 x g for 3 minutes at 4°C to remove
cellular debris. Supernatants were neutralized with 0.16 M K2CO3, kept on ice for 10
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minutes, and centrifuged at 16,000 x g for 3 min at 4°C prior to injection into the HPLC
system. Neutralized supernatants of the !BH0363 mutant were divided into two
identical samples. To one sample (spiked sample), 20 pmol of c-di-GMP was added.
HPLC separation was performed as described in by Antoniani, et al. (5).
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Chapter 3: Identification and molecular characterization of a
cyclic-di-GMP effector protein, PlzA (BB0733): evidence for the
existence of a functional cyclic-di-GMP regulatory network in
Borrelia burgdorferi

Analysis of the distribution of PlzA among pathogenic Borrelia species.
B. burgdorferi B31 possesses a single ORF (BB0733) that encodes a protein with
a PilZ domain. The consensus sequence for PilZ domains is RxxxR...D/NzSxxG with x
being any amino acid and z being any hydrophobic residue (3, 126, 134). PCR
analyses of a panel of Lyme disease isolates previously shown to carry rrp1 (125)
revealed that all harbor BB0733 (Figure 5)(Freedman, et al. 2009)(58). We have
designated this ORF as plzA. Other species of the B. burgdorferi sensu lato complex
and the relapsing fever spirochetes also possess a chromosomally-encoded PlzA
ortholog. Analysis of several recently released B. burgdorferi sensu lato complex
genome sequences indicate that some isolates possess a second gene encoding a PilZ
domain-containing protein that is present on plasmids of the lp28 group
(http://cmr.jcvi.org). Identity and similarity values for the PilZ domain-containing proteins
of the Borrelia are indicated in Table 4 and
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Figure 5. Distribution of PlzA in pathogenic Borrelia spp. The distribution of the
plzA gene in Borrelia burgdorferi, Borrelia garinii, and Borrelia afzelii was assessed by
PCR using full-length primers, and products were visualized by ethidium bromide
staining and UV detection. Strain and species designations are indicated on the top,
and ORF is indicated on the right.
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Table 4. Similarity and identity values for PlzA from Borrelia species

Identity is indicated on the top, similarity is indicated on the bottom.
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relationships to one another are displayed in the phylogenetic tree presented in Figure
6. An alignment of PilZ domain amino acid sequences with the PilZ domain residues
indicated is presented in Figure 7. To establish a workable nomenclature for the PilZ
domain-containing proteins of the Borrelia, gene/protein designations were assigned
based on phylogenetic relationships using nomenclature guidelines recommended by
the American Society for Microbiology (see Instructions for authors pertaining to journal
submissions). The chromosomal and plasmid-encoded PilZ proteins of B. burgdorferi
sensu lato complex isolates are designated as PlzA and PlzB, respectively. The PilZ
domain-containing proteins of the relapsing fever spirochetes are designated as PlzC.
The universal distribution of Rrp1 and PilZ domain-containing proteins among the
Borrelia supports the existence of a functional c-di-GMP regulatory network in all
Borrelia species.

Transcriptional analysis of plzA during in vitro cultivation, in ticks, and in infected
C3H/HeJ mice.
To determine if plzA is transcriptionally active during in vitro cultivation, in ticks
and in mammals, expression was assessed using qRT-PCR. Focusing first on in vitro
analyses, expression was determined to be constitutive and not influenced by
temperature (Figure 8A). The constitutive expression reported here is consistent with
earlier microarray analyses (22, 107, 123). plzA expression was also assessed and
detected in flat and fed infected nymphal ticks. Expression was significantly upregulated
upon feeding (Figure 8B) (p=0.0165).
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Figure 6. Phylogenetic analysis of PlzA in pathogenic Borrelia spp. A neighborjoining phylogenetic tree is presented in to show the phylogeny of PlzA in B. burgdorferi,
B garinii, and B. afzelii. The scale represents distance as the number of amino acid
changes per 100 amino acids. PlzB is included in the tree and is indicated by the
designation of its location on plasmids of the lp28 group.
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Figure 7. Consensus analysis of PlzA in pathogenic Borrelia spp. Consensus is
presented in to show the sequence homology of PlzA in B. burgdorferi, B garinii, and B.
afzelii. The scale represents distance as the number of amino acid changes per 100
amino acids.
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As a control for transcriptional transitions that occur in B. burgdorferi upon
exposure to the bloodmeal, we also determined the expression levels of the ospC gene.
As expected a dramatic increase in ospC transcript levels was observed upon feeding
(data not shown). To determine if plzA and rrp1 are produced by spirochetes during
murine infection, urinary bladders were harvested from infected mice at 2, 4, 6 or 13
weeks. The urinary bladder has been demonstrated to be the most consistent organ for
the detection of spirochetes (139), and hence transcriptional analyses were focused on
RNA extracted from this organ. Detection of the flaB transcript served as the positive
control for the detection of spirochetal RNA. Both plzA and rrp1 mRNA was detected in
the bladder at 2 weeks (Figure 8C) with transcript also detected at week 13 (the last
time point to be tested). In summary it can be concluded that plzA expression is
constitutive in vitro, is upregulated by the bloodmeal, and its expression is maintained
throughout the enzootic cycle. The expression patterns for plzB and plzC remain to be
determined.

Synthesis of c-di-GMP using recombinant diguanylate cyclases derived from B.
burgdorferi and P. aeruginosa.
To allow for the assessment of c-di-GMP binding to PlzA, c-di-GMP was
produced using B. burgdorferi Rrp1 or P. aeruginosa WspR. C-di-GMP production by
WspR was phosphate-independent, while synthesis from Rrp1 was determined to be
phosphate-dependent (Figure 9; note that due to minor differences in the HPLC
protocols used during the analysis of c-di-GMP
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Figure 8. In vitro and in vivo transcriptional analyses of rrp1 and plzA. (a) Borrelia
burgdorferi B31 grown at 23, 33, and 37°C were assessed for rrp1 and plzA expression
using qRT-PCR as detailed in the text. In all panels, the number of rrp1 or plzA
transcripts is presented as the number of copies per 100 copies of flaB. (b) The results
of qRT-PCR analysis of rrp1 and plzA in flat or fed nymphal ticks. Note that the rrp1
data in (b) are derived from an earlier analysis (125) and is included solely for
comparative reference. The absence of error bars for that specific set of data was due
to the limited amount of RNA that was available for analysis. (c) The results of qRTPCR analysis of rrp1 and plzA in the bladders of infected C3H/HeJ mice after 2, 4, 6 or
13 weeks of infection. pi, postinfection.
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production by Rrp1, there are slight differences in retention time). These findings are
consistent with earlier reports regarding the phosphate activation requirements of these
DGCs (44, 135). Both WspR and phosphate activated Rrp1 efficiently converted GTP to
c-di-GMP with no significant nucleotide contaminants or residual GTP evident in the cdi-GMP preparations (as determined by HPLC; Figure 9). The fractions containing the cdi-GMP were pooled and employed in the analyses below.

Generation of r-PlzA and r-PlzA site-directed mutants and analysis of their c-diGMP binding ability.
It has been demonstrated that R residues within the RxxxR...D/NzSxxG PilZ
domain are critical determinants for c-di-GMP binding (38, 101, 134). To gain further
insight into the determinants required for c-di-GMP binding by PlzA and to verify that the
interaction of PlzA with c-di-GMP is specific, wild type and double substitution mutants
(R150D,R154D and R150K,R154K) were tested for their ability to bind [32P]c-di-GMP.
While strong binding of [32P]c-di-GMP was observed with wild type PlzA, no significant
binding of [32P]c-di-GMP to the mutant proteins (or negative control) was observed. The
complete loss of [32P]c-di-GMP binding by the RxxxR site-directed mutants
demonstrates the absolute requirement for these residues of the PilZ domain in the
interaction between PlzA and c-di-GMP and demonstrates that the interaction of c-diGMP with PlzA is specific. Note that no binding of ["!-32P]GTP was observed to any of
the proteins.
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Figure 9. HPLC analysis of c-di-GMP synthesis by r-WspR and r-Rrp1. The ability
of r-WspR (panel a) and r-Rrp1 (panel b) to produce c-di-GMP was assessed using
HPLC. The top graph demonstrates the retention time of GTP with no protein added.
This control is presented for both WspR and Rrp1 since slightly different solvent
conditions were used with each protein. r-WspR and r-Rrp1 were incubated with or
without acetyl phosphate (+AcP or -AcP, as indicated in the figure) before the addition
of GTP to assess the dependence of c-di-GMP production on phosphate activation. The
r-proteins were then incubated with GTP and the nucleotide products were analyzed by
HPLC as detailed in the text. Note that the slight differences in the retention times for cdi-GMP generated with r-Rrp1 and r-WspR are the result of slight differences in solvent
conditions for each run.
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demonstrating that the interaction is specific for c-di-GMP. In summary, these data
represent the first direct demonstration of c-di-GMP binding to a spirochetal protein and
support the hypothesis that PlzA is a functional component of the c-di-GMP regulatory
network (Figure 10).

Discussion
Recently, c-di-GMP has come to the forefront of study of the prokaryotic
kingdom, as a major regulator of cellular processes (reviewed in (41, 69)). While DGC,
PDE, and PilZ domain-containing proteins are widely distributed amongst the
eubacteria, many remain uncharacterized. For example, among the spirochetes, only a
single DGC has been partially characterized, and there are only limited published
analyses of PDE or PilZ proteins (80, 116, 125, 135, 159, 160). In several organisms
such as Vibrio cholera, Shewanella oneidensis, and Escherichia coli, the analysis of
specific proteins of the c-di-GMP regulatory network, with regards to bacterial
physiology, is complicated by the functional redundancy of their output domains (91,
164). Borrelia spp. serve as an ideal model system for studying c-di-GMP, due to the
fact that they only encode one DGC (BB0419 - Rrp1), two PDEs (BB0363 - PdeA and
BB0374 - PdeB) and one PilZ domain-containing protein (BB0733 - PlzA) (28, 68, 80,
116, 125, 159, 160). The major goals of this study were to determine if PlzA is
universally encoded amongst B. burgdorferi sensu lato complex isolates from diverse
geographical and enzootic niches, transcribed during specific phases of the Lyme
disease enzootic cycle, and if it has potential to serve as a downstream effector protein
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Figure 10. C-di-GMP binds to PlzA of Borrelia burgdorferi with high specificity. RPlzA, r-PlzA mutants R150D,R154D and R150K,R154K, and r-Rrp1 were expressed as
N-terminal MBP fusions and were assessed for their ability to bind to [32P]c-di-GMP.
The r-proteins used in the analyses are designated across the top of the panels. The
ratio of competing nucleotide to [32P]c-di-GMP is indicated to the right (no competitor
was added in the top panel). The second panel from the bottom was screened with [#32
P]GTP alone (with no c-di-GMP added) and the bottom panel is a Western blot using
anti-MBP antibody.
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in the c-di-GMP regulatory network via the binding of c-di-GMP.
As demonstrated through PCR analyses and bioinformatic analyses of recently
published genome sequences of B. burgdorferi sensu lato isolates, we found that the
gene encoding PlzA is universally distributed amongst all Borrelia isolates analyzed and
is present in all Borrelia species for which genome sequences are currently available.
Interestingly, several isolates of B. garinii and B. burgdorferi encode for two PilZ
domain- containing proteins, where one is encoded for on the linear chromosome and
the other by a linear plasmid of 28 kb (lp28 group). The protein sequence of the
chromosomally-encoded PilZ domain-containing protein is significantly conserved
amongst B. burgdorferi sensu lato complex isolates (identity values >90%) and as such,
represents a conserved distribution of a PlzA ortholog. Additionally, the plasmid-carried
PilZ domain-protein sequences are equally as distant from PlzA (amino acid identity,
~64%) as the chromosomally-encoded PilZ-domain sequences of the TBRF Borrelia are
to the B31 PlzA sequence (identity values of ~65 to 69%). Based upon protein
sequence alignments and phylogenetic analyses, the lp28-encoded PilZ domain ORF of
B. burgdorferi sensu lato isolates, and the chromosomally-encoded PilZ domain of the
TBRF Borrela, exhibit enough divergence to warrant separate gene titles – proposed as
PlzB and PlzC, respectively. It is noteworthy that the domains associated with the
synthesis/breakdown of c-di-GMP or effector functions of c-di-GMP are located in
proteins that possess differing output domains. This suggests that PlzA, PlzB, and PlzC
may respond differently to the binding of c-di-GMP. Plz proteins of the Borrelia do not
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harbor identifiable functional domains other than the PilZ-domain involved in c-di-GMP
binding, making potential mechanisms of action difficult to predict.
In studies published by Rogers, et al., it was demonstrated that rrp1 of B.
burgdorferi is constitutively transcribed during in vitro cultivation and that its transcription
is upregulated in ticks following a bloodmeal of mammalian origin (125). We
hypothesized that because Rrp1 and PlzA appear to be functionally linked, that PlzA
and Rrp1 would have similar expression patterns. plzA transcript was detected under all
environmental conditions tested (23, 33, and 37°C) and no significant changes in
expression levels were documented. However, plzA transcription was significantly
upregulated in fed versus flat nymphal ticks, indicating that factors in the bloodmeal
trigger transcription through unknown mechanisms. The elevated temperature
encountered during tick feeding does not appear to be a source of rrp1/plzA expression,
because temperature did not have an effect on plzA expression during in vitrocultivation of B. burgdorferi. The molecular signal(s) resulting in the upregulation of
plzA upon tick feeding are not yet known. One possibility is that rrp1, which is also
upregulated by the bloodmeal, directly or indirectly influences plzA transcription through
the synthesis of c-di-GMP. In earlier and more recent microarray studies, the
inactivation of rrp1 did not lead to a repression of plzA (28, 68, 125). As such, it is
hypothesized that Rrp1, c-di-GMP, or an unidentified effector molecule involved in c-diGMP genetic and/or physiologic regulation serves as a transcriptional activator of plzA
that enhances its expression above threshold levels. Expression of plzA and rrp1 was
also assessed during murine infection. Expression of plzA and rrp1 was detected in the
urinary bladders of infected mice throughout the 13 week infection period. Collectively,
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these data suggest that the synthesis of c-di-GMP and its downstream effector(s)
contributes to to the proper regulation of cellular processes during the enzootic cycle of
the Lyme Borrelia.
While the presence of the c-di-GMP binding switch of the PilZ domain is
indicative of c-di-GMP binding activity, it was necessary to directly demonstrate this
activity for PlzA. For these analyses, r-DGC proteins were constructed, purified, and
used to produce radiolabeled or nonradiolabeled c-di-GMP, and then used to assess
binding to PlzA. A c-di-GMP/r-PlzA complex was readily detected using an overlaybased approach. C-di-GMP binding to PlzA was specific, as only trace levels of binding
to Rrp1 were observed. The nucleotide binding specificity of PlzA was assessed using
several different nucleotides as nonspecific and nonlabeled competitors. As predicted,
excess unlabeled c-di-GMP substantially decreased the binding of radiolabeled c-diGMP to PlzA, indicating saturable binding and competitive inhibition. None of the other
tested nucleotides influenced the binding of radiolabeled c-di-GMP to PlzA when
present in vast excess. These analyses confirm the highly specific nature of the
interaction between c-di-GMP and PlzA.
To more adequately assess the molecular determinants involved in c-di-GMP
binding by PlzA, site-directed mutants of PlzA were generated and tested for c-di-GMP
binding. The targeted Arg residues of the c-di-GMP binding switch were chosen based
upon similar analyses of the YcgR PilZ domain-containing protein of E. coli (134) in
which Arg residues within the PilZ domain were demonstrated to be essential for
binding. We generated r-proteins containing two double amino acid substitutions;
R150D,R154D and R150K,R154K. Both mutants were readily expressed by E. coli and
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were soluble. Neither mutant bound c-di-GMP indicating that the amino acid
substitutions perturb the molecular binding determinants of PlzA. These data confirm
the importance of the Arg residues in the c-di-GMP binding switch of the PilZ domain
and provide further evidence that the interaction of c-di-GMP with PlzA is highly specific.
In summary, in this study we demonstrate that B. burgdorferi encodes for a
functional c-di-GMP binding protein that we have designated as PlzA. PlzA expression
was observed during both tick and mammalian stages of the enzootic cycle of the Lyme
spirochetes. Binding analyses utilizing site-directed mutants of PlzA, as well as
competitive inhibition experiments using excess amounts of different nucleotides,
demonstrated that the interaction between PlzA and c-di-GMP is highly specific. The
basic characterization of PlzA presented here is an important step forward in the
understanding of the c-di-GMP regulatory network of the Lyme disease spirochetes.
The analyses detailed within provide insight into a potential functional linkage between
Rrp1, c-di-GMP, and PlzA, in terms of the hypothesized regulatory cascade driven by cdi-GMP. Specific roles of PlzA and the processes that it influences are described in the
following chapter.

Acknowledgements
We thank Durland Fish (Yale University) for providing I. scapularis larvae and
Christopher G. Earnhart (Virginia Commonwealth University) for providing the pTYB12wspR vector for expression of WspR.

78

Chapter 4: Analysis of the impact of the PilZ-domain containing
proteins, PlzA and PlzB, on motility and the enzootic cycle of the
Lyme disease spirochetes

plzB is variably distributed throughout Borrelia burgdorferi sensu lato
Previously and through the use of bioinformatic analyses, we identified a paralog
of plzA, that is harbored on a linear plasmid of 28 kb (lp28) in certain sequenced B.
burgdorferi and B. garinii isolates (58). Using genomic DNA from a library of isolates
obtained from a wide array of geographic locations and sources, we conducted PCR
analyses to assess the distribution of the plzB gene. It was found that 9 out of the 22
additional strains tested contained the gene (data not shown). Strains 20004, CA3,
CA8, CA12, CA-2-72, CA-2-87, MAC13, NY-1-86, R1000, and VS293 contained the
allele, and certain strains contained a deletion mutation, creating a truncated protein
lacking the c-di-GMP binding switch of the PilZ domain. It was determined that the
distribution of plzB did not depend upon the geographic origin or animal/tissue source.
Additionally, there was no correlation between MLST (multilocus sequence typing) type
and the distribution of this gene.
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PlzB is a cyclic-di-GMP binding PilZ domain protein
To determine whether or not PlzB was capable of binding c-di-GMP, overlay
assays were performed as previously described (58). r-PlzB, r-PlzA (positive control),
and r-Rrp1 were spotted onto nitrocellulose and screened in the presence of [32P]c-diGMP with or without cold, competitor nucleotides as indicated in Figure 11. Binding to
PlzB was demonstrated by a decrease in signal with a 375:1 excess of cold c-di-GMP,
and a lack of signal decrease with GTP, GMP, cGMP, cAMP, and ATP. Thus, like PlzA,
PlzB is a c-di-GMP binding protein with high specificity for its ligand.

Allelic exchange mutagenesis: inactivation of plzA, complementation with plzA
and plzB, and analysis of mutant growth rates
In order to examine the effects of PlzA and PlzB on the motility, chemotaxis, and
processes important in the enzootic cycle of B. burgdorferi, plzA was inactivated by the
insertion of a spectinomycin/streptomycin resistance cassette (B31-!plzA).
Additionally, two complementary mutants were made. The first contains plzA in the wild
type locus (BB0733)(B31-plzA KI), and the second placed plzB into the same genomic
location (B31-plzB KI). Both complementation mutants contain a kanamycin resistance
cassette 3’ to the gene insertion and were selected for by growth in BSK-H containing
kanamycin (Figure 12A). Successful deletion and complementation of plzA/plzB was
confirmed via PCR analyses using primers specific for regions within the genome and
the insertion (Figure 12B). Additionally, expression of the allelic exchange mutants was
confirmed via reverse transcriptase PCR (Figure 12C).
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Figure 11. PlzB is a PilZ domain-containing protein that binds c-di-GMP with high
specificity. R-PlzB,, and r-Rrp1 were expressed as N-terminal MBP fusions and were
assessed for their ability to bind to [32P]c-di-GMP. The r-proteins used in the analyses
are designated across the top of the panels. The ratio of competing nucleotide to [32P]cdi-GMP is indicated to the right (no competitor was added in the top panel). The second
panel from the bottom was screened with [#-32P]GTP alone (with no c-di-GMP added)
and the bottom panel is a Western blot using anti-MBP antibody.
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Figure 12. Characterization of plzA allelic exchange and deletion mutants. (A)
Wild type and allelic exchange mutants were constructed by the deletion or
complementation of the chromosomally-encoded BB0733. Diagrams represent the
genomic arrangement of wild type, deletion, and complemented strains. (B) Successful
deletion and complementation mutants were confirmed by PCR analysis. Primer pairs
are indicated spacially in panel A, and the respective strain designations are shown on
the top. (C) Expression of plzA and plzB were demonstrated via reverse transcriptase
PCR. The genes analyzed are shown on the left, and again, the strain designations are
shown on top.
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Because plasmids of Borrelia spp. are frequently lost during cultivation and
transformation/electroporation, the total plasmid content of clonal populations of all
mutants was assessed by PCR using primers specific for ORFs harbored on each of
plasmids of B. burgdorferi 5A4 (Table 3). Clones containing the full repertoire of
plasmids were selected and used in later analyses.
To assess the effects of deletion and allelic replacement of plzA on potential
growth defects of these strains, clonal populations of B31-!plzA, B31-plzA KI, and B31plzB KI were assessed for growth rates at 33°C and 37°C. Both the knockout and plzA
complement displayed similar growth rates to wild type B. burgdorferi, 5A4, while the
plzB complemented strain displayed a slightly reduced growth rate during logarithmic
phase, and was unable to reach numbers as high as the wild type (Figure 13). The
above work was conducted in collaboration with Jessica L. Kostick and Dr. Beth Rogers
Abdunnur.

plzB is unable to complement plzA motility functions
In order to assess the potential roles of plzA and plzB in the motility of B.
burgdorferi, swarming assays and video-tracking experiments were performed. Swarm
assays were conducted in semi-solid media containing BSK-H complete and agarose
(0.35%). Relative to wild type, B31-!plzA demonstrated a swarm diameter that was
56.7% decreased, and B31-plzB KI demonstrated swarm diameters with a decrease of
68.7% (Figure 14). These differences were determined to be significant and p-values
are indicated in Figure 14. Motility patterns were assessed in BSK-H complete growth
media containing 1% methylcellulose. Methylcellulose increases media viscosity by
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Figure 13. Growth rates of plzA allelic exchange/deletion mutants. Growth of
B31-!plzA, B31-plzA KI, and B31-plzB KI were assessed at 33, and 37°C by
microscopic analysis until stationary phase was reached. Equal numbers of cells were
used to start cultures, and 10 40x fields were counted each day. B31-!plzA and B31plzA KI displayed similar growth rates at all temperatures tested, and B31-plzB KI
displayed a slightly slower growth rate during logarithmic phase and did not reach levels
as high as wild type.
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Figure 14. PlzA but not PlzB, regulates the swarming motility of B. burgdorferi. (A)
Wild type and mutant B. burgdorferi strains were assessed for their ability to swarm in
semi-solid agarose BSK-H plates. Spirochetes (5 x 105 ) were spotted into plates at day
0, and swarm diameters were measured at days 2, 4, and 6. Assays were performed in
triplicate, and significance was assessed by Student’s t-test with a confidence interval of
95%. (B) Images of representative swarm diameters were taken at days 2, 4, and 6.
Strain designations are shown on the left axis and the day is indicated at the top. Soft
agar swarming assays were performed by Jessica L. Kostick.
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creating a matrix through which the spirochetes are able to move (130). Twenty
spirochetes were used to calculate all measurements. Both B31-!plzA and B31-plzB KI
had slower average run speeds (1.6500 ± 0.7339 "m/sec and 1.5793 ± 0.7369 "m/sec,
respectively) and decreased flexes (0.0783 ± 0.0313 flexes/second and 0.0078 ±
0.0109 flexes/second) relative to B31-wt. The average velocity for B31-wt was 4.1578±
0.7788 "m/sec and the average flexes were 0.0783 ± 0.0313 . As expected, B31-plzA
KI displayed similar average run velocities and flexes/second to that of the wild type
strain (Table 5 and Figure 15). These differences were determined to be significant with
p-values < 0.0001. Taken together, the swarm assay and video tracking analyses
demonstrate that plzA is important for the proper regulation of motility as well cellular
flexing during motility via unknown mechanisms, and that plzB is unable to complement
for these functions. Motion-tracking analyses were performed by Dr. Lee T. Szkotnicki.
Defects in the chemotaxis of the plz mutants towards N-acetyl-glucosamine were not
detected, indicating that PlzA and PlzB do not play a role in the chemotaxis of B.
burgdorferi (Jessica L. Kostick, unpublished data).

plzA, but not plzB, plays a role important in murine infectivity
Subcutaneously needle-inoculated mice were sacrificed at 4 weeks postinoculation and assessed for infection by wild type, B31-!plzA, B31-plzA KI, and B31plzB KI, using seroconversion analyses and observation of outgrowth of spirochetes
from biopsied tissues. Mice infected with B31-!plzA and B31-plzB KI displayed
markedly reduced anti-Borrelia IgG titers compared to that of wild type and B31-plzA KI
(Figure 16A). Low level IgG titers were similar to those observed in previous infection
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Table 5. Average run velocity and flexes/sec of B. burgdorferi plzA mutants
Strain

Average Run Velocity

Flexes/sec

B31-wt

4.1578± 0.7788 "m/sec

0.0783 ± 0.0313

B31-!plzA

1.6500 ± 0.7339 "m/sec

0.0043 ± 0.0115

B31-plzA KI

4.1706 ± 0.8714 "m/sec

0.1024 ± 0.0541

B31-plzB KI

1.5793 ± 0.7369 "m/sec

0.0078 ± 0.0109
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Figure 15. PlzA but not PlzB regulates motility patterns of B. burgdorferi. Motility
in BSK-H complete media with 1% methylcellulose was examined using differential
interference contrast (DIC) microscopy. Movies of spirochetes were recording using
time-lapse photography and were analyzed using Slidebook 5 motion-tracking software
(Intelligent Imaging Innovations). Measurements of velocity were calculated using 20
motion-course tracks per strain, Images of representative fields/spirochetes are shown
at 0, 5, 10, and 20 seconds. Course of movement is indicated by the rainbow-colored
line, with movement progressing from violet to red and strain designation is shown on
the top of the image.
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studies (48, 80). To compare the pattern of antigen recognition of mice infected with
each strain, immunoblots screening B. burgdorferi 5A4 whole cell lysates were
performed. As expected based upon the ELISA IgG titer assays, serum from
miceinfected B31-!plzA and B31-plzB KI did not recognize any proteins. No
differences in antigenic profile were observed between the wild type strain and B31-plzA
KI (Figure 16B).
In order to assess infectivity and dissemination, outgrowth of spirochetes from
biopsied organs was assessed. As expected from the seroconversion data, no
spirochetes were observed in mice inoculated with B31-!plzA and B31-plzB KI.
Outgrowth of spirochetes from the skin, heart, and urinary bladders were observed in all
mice infected with wild type and B31-plzA KI strains (Table 6). From these data, it can
be concluded that PlzA is required for mammalian infection and that PlzB is unable to
complement for its functions during the mammalian stage of the enzootic cycle. These
studies were performed in collaboration with Jessica L. Kostick.

plzA is nonessential for survival in ticks, but is required for murine infection via
tick bite; plzB cannot complement this function
Several components of the B. burgdorferi c-di-GMP signaling network have been
shown to be important in the survival of Ixodes scapularis ticks (28, 68, 80, 159, 160).
To assess survival in artificially infected ticks, mouse-independent immersion
inoculation was performed. Naïve larval ticks were submerged in BSK-H complete
media containing 108 spirochetes/mL, allowed to dry for one week, and fed to repletion
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Figure 16. PlzA regulates processes important in mammalian infection. C3H/HeJ
murine subjects were inoculated subcutaneously with wild type, B31-!plzA, B31-plzA
KI, and B31-plzB KI strains. At 4 weeks, serum was harvested and IgG titers were
assessed by ELISA. Strain designations are shown on the bottom, and horizontal lines
indicate the mean Log (Anti-Borrelia IgG titer). Individual points represent titers for
individual mice (A). Patterns of antigen recognition were assessed by immunoblotting
against B. burgdorferi whole cell lysates (B). P-values were determined in comparison
to B31-wt.
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B)
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Table 6. Outgrowth of spirochetes from murine biopsies
Strain

Bladder

Heart

Skin (ear)

B31-wt

5/5

5/5

5/5

B31-!plzA

0/5

0/5

0/5

B31-plzA KI

5/5

5/5

5/5

B31-plzB KI

0/3

0/3

0/3
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on naïve C3H/HeJ mice. Ticks were collected, and assessed by qPCR for the presence
of spirochetes. Spirochetes from each strain (wild type, B31-!plzA, B31-plzA KI, and
B31-plzB KI were detected in the majority of artificially infected I. scapularis ticks. Thus,
plzA is dispensible for spirochete survival in larval I. scapularis ticks (Table 7).
To examine whether plzA can allow for infection of mice via the natural route, and
whether or not plzB can complement its function, infected ticks were placed onto naïve
C3H/HeJ mice. Four weeks post-feeding, mice were sacrificed and serum was
collected for seroconversion analyses. As was seen for the needle inoculated mice,
B31-!plzA and B31-plzB KI displayed markedly reduced titers as compared to the wild
type and B31-plzA KI strains. Taken together, these results demonstrate that PlzA is
nonessential for survival in ticks, but is required for murine infection via tick bite, and
also that PlzB cannot complement PlzA function during tick transmission and/or mouse
infection (Figure 17). This work was conducted in collaboration with Jessica L. Kostick,
Dr. Lee T. Szkotnick, and Katie Mallory.

Discussion
To date, species of the genus Borrelia are the only spirochetes in which c-diGMP signaling has been studied. In staying with the theme that c-di-GMP acts as a
molecular “on-off switch” for the regulation of opposing phenotypes (37, 76, 94, 111,
115, 117, 146), it is logical that the second messenger would regulate processes
important in an organism that must withstand vastly different environments in a two-host
enzootic cycle. The cascade of c-di-GMP signaling in B. burgdorferi, begins with
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Table 7. PlzA regulation of tick survival by B. burgdorferi
Strain

B31-wt

# of Borrelia positive
ticks after mouseindependent immersion
inoculation (qPCR)
10/10

# of seroconversion
positive mice after
infected tick feeding
(ELISA)
3/3

B31-!plzA

8/10

0/3

B31-plzA KI

8/10

1/3

B31-plzB KI

8/10

0/3
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Figure 17. PlzA is necessary for the transmission of B. burgdorferi to mammalian
hosts during the tick-mouse-tick enzootic cycle. Artificially infected ticks were
placed onto naïve mice and allowed to feed to repletion. Following feeding, ticks were
harvested, and mice were held for 4 weeks to allow potential infection and
dissemination to progress. At 4 weeks, mice were sacrificed and analyzed by ELISA for
seroconversion. Strain designations are shown on the bottom, and horizontal lines
indicate the mean Log (Anti-Borrelia IgG titer). Individual points represent titers for
individual mice.
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activation of Hk1, phosphotransfer to Rrp1, and synthesis of c-di-GMP. Rrp1, and
presumably c-di-GMP have demonstrated to be important in motility, chemotaxis, and
processes important in tick survival and mammalian infectivity (28, 68, 80, 125).
Likewise, the EAL domain-containing PDE, PdeA, the HD-GYP domain-containing
protein, PdeB, and the PilZ domain-containing protein, PlzA have been demonstrated to
be important in similar processes (116, 159, 160). This study further supports the.
context of the literature, that c-di-GMP is an important molecule in vivo in the life cycle
of B. burgdorferi
Because c-di-GMP exerts its effects through the interaction with down stream
effector molecules such as PilZ-domain containing proteins, transcriptional regulators,
and GEMM RNA riboswitches (3, 13, 58, 71, 79, 83, 101, 134, 150), we desired to
assess the effects of PlzA and the variably distributed PlzB PilZ domain-containing
proteins of B. burgdorferi on motility, chemotaxis, and ability to complete the tick-mouse
enzootic cycle (58). Previous studies by our lab demonstrated that plzA is widely
distributed across the genus, that plzA is upregulated at the time of tick feeding,
expressed during mammalian infection, and that PlzA is capable of binding to c-di-GMP
in a highly specific manner, in vitro. Taken together, these data suggest that PlzA is a
c-di-GMP effector protein, important in the enzootic cycle of the Lyme disease
spirochetes (58).
In previous studies, it was found through bioinformatics analysis, that certain
Lyme Borrelia harbor a second, plasmid (lp-28) harbored PilZ domain-containing
protein, which we named PlzB. PlzB harbors a putative PilZ domain, and shares 64.4
and 80.5% identity and similarity with PlzA from B. burgdorferi B31. The majority of
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homology exists within c-di-GMP binding switch region harboring the
RxxxR…D/NzSxxG binding motif (58). To further assess the distribution of plzB
amongst the Lyme disease spirochetes, we performed PCR using plzB-specific primers
and a library of genomic DNA from a wide array of geographic and host-derived
sources. Similarly to what is seen in the literature, approximately 40% of the isolates
tested contained the plzB allele (58). Sequence analysis of the amplified plzB alleles
showed that certain alleles encode truncated proteins lacking a PilZ domain. Full length
plzB amplified from B. burgdorferi strain CA12 was used in all biochemical and ex and
in vivo analyses, and is identical in sequence to PlzB of B. burgdorferi strain 64b.
In order demonstrate that PlzB is a c-di-GMP binding protein, overlay assays
were performed as previously described (58, 117). Like PlzA, PlzB binds c-di-GMP with
high specificity. While we did not assess the roles of the arginine residues in the c-diGMP binding switch of PlzB, it is highly likely that they are essential for c-di-GMP
binding as has been demonstrated for PlzA and other PilZ domain-containing proteins
(37, 58, 101, 134). Based upon the similarity of the c-di-GMP binding switch regions of
PlzA and PlzB, it is likely that these proteins evolved concurrently, and evolved separate
functions and/or genomic locations at a later time.
In these studies, we generated a series of plzA allelic exchange mutants (B31!plzA, B31-plzA KI, and B31-plzB KI) and utilized them to analyze the effects of PlzA
and PlzB on motility, chemotaxis and tick/mouse survival, infectivity, and transmission processes demonstrated to be affected by c-di-GMP signaling in Borrelia and other
prokaryotic organisms. Deletion of plzA resulted in reduced swarming on semi-solid
media, and additionally resulted in slower velocity and decreased flexing as noted by
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DIC microscopy. Not surprisingly, PlzB, which only shares moderate homology with
PlzA, was unable to complement the functions of the chromosomally-encoded PlzA.
These analyses demonstrate that PlzA positively regulates the proper motility of B.
burgdorferi, but that PlzB cannot complement for defects in PlzA signaling. While the
differences in chemotaxis were not significant between Plz mutants, these data may
suggest that PlzA and PlzB have evolved separate functions, where PlzA directly or
indirectly regulates motility and PlzB regulates unknown or yet-to-be described
processes. PilZ domain-containing proteins have been shown to regulate motility and
chemotaxis in the enterobacteria (YcgR) and Caulobacter crescentus (DgrA), via
interaction with proteins of the flagellar motor (3, 20, 37, 39, 111, 134). It may be that B.
burgdorferi and other Lyme spirochetes have evolved similar PilZ-flagellar interactions
in order to quickly translate environment cues into increased motility and/or chemotaxis,
processes potentially important during tick transmission and mammalian infection.
Likewise, the c-di-GMP-PlzA/PlzB interaction may affect motility and/or chemotaxis via
other yet-to-be described mechanisms.
Needle inoculation of C3H/HeJ mice with wild type B. burgdorferi strain 5A4,
B31-!plzA, B31-plzA KI, and B31-plzB KI imply that PlzA is required for mammalian
infectivity, and that PlzB cannot complement PlzA functions important in infection and/or
dissemination. These observations are based upon seroconversion and tissue
outgrowth experiments. Additionally, PlzA was dispensable for survival in larval Ixodes
scapularis ticks (fed via submersion), and PlzB had no further positive or negative
effects. As expected, B31-!plzA and B31-plzB KI were unable to be transmitted to
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mice fed on by infected I. scapularis ticks. While it is possible that these strains do not
traffic correctly through the tick for natural infection, they were both non-infectious by
needle inoculation as previously mentioned. Taken together this study demonstrates
the importance of PlzA in motility and steps important in the enzootic cycle of the Lyme
spirochetes, as well as the potential importance of PlzB in chemotaxis. It is possible
that while PlzB does not complement the phenotypes associated with loss of PlzA, that
PlzB may offer strains harboring the plzB gene on an lp-28 advantages in chemotaxis
towards mammalian factors during transmission, or tick acquisition of infecting
spirochetes. Other potential roles cannot be discounted. Unfortunately, because B31!plzA and B31-plzB KI were noninfectious, tick acquisition experiments were unable to
be performed. While certain strains of B. burgdorferi have evolved and maintained
plzB, it still remains unclear what advantages this second allele may have in nature.
Further studies will have to performed utilizing a plzB-lacking strain, expressing a
plasmid-carried plzB to tease apart the intricacies of PlzB function in the presence of
PlzA.
Like the other signaling components of the c-di-GMP signaling network of B.
burgdorferi, PlzA and potentially PlzB, may be important for process important in the
enzootic cycle and survival in nature by the Lyme disease spirochetes (28, 58, 68, 80,
116, 125, 159, 160). The results here are only somewhat in agreement to what was
observed by Pitzer et al. (116). Those studies demonstrated that PlzA is not required
for infection and that a plzA deletion mutant showed decreased survival in ticks.
Additionally, the plzA null strain created by Pitzer et al., did not exhibit different motility
patterns in 1% methylcellulose. While there is a discrepancy with these data presented
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here, two different parent strains were utilized. (116). While not all of the nuances of cdi-GMP signaling are understood in B. burgdorferi, it appears as if the synthesis,
breakdown, and binding of c-di-GMP is a fine-tuned system. Deletion of the
components of c-di-GMP signaling in B. burgdorferi has revealed discrepant
phenotypes. For example, strains lacking Rrp1 or PdeA (low or high levels of c-di-GMP,
respectively) both demonstrate decreased motility and survivability in ticks (28, 68, 80,
160). It may be that processes important in tick survival, acquisition, and/or
transmission are highly regulated and extremely fine-tuned at the level of c-di-GMP
synthesis and breakdown, affecting different processes as the spirochetes encounter
differing environments within the tick and/or mammalian host. Disregulation of c-diGMP levels at different times during the enzootic cycle may be deleterious to Borrelia
survival. The importance of c-di-GMP and its role in motility/chemotaxis in vivo remains
to be determined, but it may be that motility is important in trafficking through the tick
vector or into deeper tissues in mammalian infection. Regardless, the phenomena
described here support the notion that c-di-GMP signaling is important in the enzootic
cycle of B. burgdorferi. These analyses identify potential roles for the two known c-diGMP binding proteins of B. burgdorferi, and strengthen our understanding of PilZ
domain-containing proteins of the spirochetes. While it remains to be determined what
the mechanism of action of the Borrelia Plz proteins is, the analyses here provide a
framework for piecing together the intricate puzzle of c-di-GMP signaling in B.
burgdoferi.
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Chapter 5: Metabolism of c-di-GMP in the tick-borne relapsing
fever spirochete, Borrelia hermsii, plays an integral role in motility
and virulence

Rrp1 is a phosphorylation-dependent, response regulator/diguanylate cyclase
protein
Recently, it was demonstrated that Rrp1 of B. burgdorferi exhibits DGC activity
when in an “activated”, phosphorylated state. To show that Rrp1 of B. hermsii is also a
hybrid response regulator/DGC, we carried out in vitro c-di-GMP synthesis assays as
previously described (58, 135). Because r-Hpk1 was unavailable as a source of
phosphotransfer, we used acetyl phosphate (AcP) as a phosphate donor in order to
phosphorylate the receiver domain of r-Rrp1. Following incubation with AcP, and
subsequent incubation with GTP, r-Rrp1 produced c-di-GMP as indicated by a retention
time equal to that of the c-di-GMP standard. As expected, in the absence of AcP, rRrp1 does not produce c-di-GMP. Instead, it appeared as if r-Rrp1 broke GTP into two
unidentified products. Because neither observed peak was retained equally to GTP or
GMP standards, we are unable to say what either of the peaks may be. However,
based upon the data, it is clear that Rrp1 of B. hermsii is a phosphorylation-dependent
response regulator/DGC hybrid protein (Figure 18).
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PdeA is an EAL domain-containing phosphodiesterase
Previously, bioinformatics analysis and later biochemical evaluation revealed that
PdeA of B. burgdorferi is an active EAL domain-containing PDE (160). To determine
the functionality of PdeA of B. hermsii, we used an approach utilized by Tamayo et al.
and Sultan et al. (160, 163). r-Rrp1 from B. hermsii was used to synthesize [32P]c-diGMP, which was used in this analysis. [32P]c-di-GMP was incubated with our negative
(r-PlzA) and positive controls (snake venom phosphodiesterase; SVPD), or r-PdeA with
Mg2+ in the presence or absence of Mn2+. After incubation with c-di-GMP, we found that
PdeA breaks down the second messenger nucleotide into linear-di-GMP (l-di-GMP, or
pGpG) as indicated by the spot migrating with a retention factor (Rf) value of 0.55, and
the increase in intensity of this spot over time (Figure 19). Unlike B. burgdorferi PdeA,
we did not observe increased activity in the presence of Mn2+.

Generation and characterization of a !rrp1 and !pdeA deletion mutant and
complement strains.
Recent advances in the techniques used to transform B. hermsii have allowed us
to assess the role c-di-GMP metabolism has on the motility, chemotaxis, and infectivity
of B. hermsii DAH (12, 53). To assess this, we replaced both pdeA and rrp1 with a
tandem gentamicin (gentR) resistance-green fluorescent protein (gfp) cassette. The
resulting strains were designated BhDAH"rrp1 and BhDAH"pdeA (Figure 20A). We
also generated a cis-complemented strain through introduction of the wild type genes
appended with a downstream tandem kanamycin (kanR) resistance-gfp cassette.
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Figure 18. Rrp1 of B. hermsii is a GGEEF domain-containing protein exhibiting
DGC activity. The ability of r-Rrp1 to produce c-di-GMP was assessed using HPLC.
The top graphs demonstrate the elution volumes (mL) of the indicated nucleotides . rRrp1 was incubated with or without acetyl phosphate (+AcP or -AcP, as indicated in the
figure) before the addition of GTP to assess the dependence of c-di-GMP production on
phosphate activation. The r-proteins were then incubated with GTP and the nucleotide
products were analyzed by HPLC as detailed in the text.
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Figure 19. PdeA of B. hermsii is a c-di-GMP specific EAL phosphodiesterase.
The ability of r-PdeA to break c-di-GMP into l-di-GMP was assessed using TLC. rPdeA, positive (SVPD), and negative controls were incubated with [32P]c-di-GMP for
one hour at room temperature. Reactions were then spotted onto PEI-cellulose
membranes at 0, 15, 30, 45, and 60 minutes to stop the reaction. Reactions took place
in the presence or absence of Mn2+ as indicated by the “+” or “-“ symbols at the bottom
of the figure.
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These strains were designated BhDAHrrp1::kanR and BhDAHpdeA::kanR (Figure 20B).
Clonally-derived populations of both deletion and complemented strains were isolated
through the use of limiting dilution, and proper insertion of the gentR-gfp or rrp1/pdeAkanR-gfp cassettes was confirmed via PCR using primers designated in Figures 21A,
21B, and Table 3 (Figure 20C). Growth curve analysis was performed to identify any
possible growth defects associated with any of the insertions in their respective genomic
locations. All B.hermsii cultures appeared to have similar growth rates at all tested
temperatures (Figure 20D). Electroporation of a related spirochete B.burgdorferi often
results in loss of DNA elements (86, 118, 127). This often results in loss of genes
required for mammalian infectivity and tick survival, acquisition, and transmission (26,
145, 173). Typically B. burgdorferi plasmid content is determined though a series of
plasmid-specific PCR reactions (97). As the sequences for all B. hermsii plasmids are
not yet available, we used PFGE to assess plasmid content in our knockout and
complement strains (Figure 20E). As determined by PFGE, there were no visible
changes in the plasmid profile of the deletion and complemented strains. To further
assess these strains, we performed SDS-PAGE and Coomassie R-250 staining to
determine if gross alterations in protein profile were observed in any of the strains used
in these studies. No changes were detected (Figure 20F). This work was performed in
collaboration with Dr. Lee T. Szkotnicki and Katie Mallory.

115

Figure 20. Generation and characterization of a !rrp1 and !pdeA deletion mutant
and complement strains. To determine if cyclic-di-GMP metabolism influences the
pathogenesis of B. hermsii, null strains BhDAH"pdeA and BhDAH"rrp1and allelic
replacement strains BhDAHpdeA::kanR and BhDAHrrp1::kanR were generated using
allelic exchange mutagenesis (B). PCR confirmed proper integration (C). Primer
locations are indicated in A and B. Growth rates were determined at 25, 33, and 37°C
(D)(Graph representative of 37°C). Linear plasmid profile was determined for each
strain by pulsed-field gel electrophoresis (E). A total protein profile for each tested
strain was obtained by running cell lysate on an acrylamide gel and subsequently
staining with coomassie blue (F).
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B. hermsii cells lacking pdeA accumulate cyclic-di-GMP compared to the wild
type and rrp1 mutant
In order to understand the role of c-di-GMP in the TBRF spirochete, B. hermsii, it
was essential to determine the intracellular levels both in wild type and mutant strains.
C-di-GMP content was determined in all B. hermsii strains by HPLC analysis as
described in Antoniani et al. (5). C-di-GMP was detected in the BhDAH"pdeA strain, as
demonstrated by the spiked c-di-GMP standard co-eluting with the peak from the acidsoluble phase from this strain (Figure 21A). Notably, the peak was not detected in the
wild-type, BhDAH"rrp1, BhDAHrrp1::kanR or BhDAHpdeA::kanR strains. (Figure 21AB). The peak identified in the BhDAH"pdeA mutant was confirmed by identical UV
absorption with c-di-GMP standard (not shown) and by the increase of the peak area of
the c-di-GMP peak when purified c-di-GMP was added to the BhDAH"pdeA acidsoluble extract (Fig 21C). Cyclic-di-GMP content in the BhDAH"pdeA mutant strain
was normalized to the cell dry weight and was determined to be 1.83 + 0.2 pmol/mg.
This work was performed in collaboration with Paola Bocci and Nadia Raffaeli
(Univesita Politechnica delle Marche).

Loss of both rrp1 and pdeA result in an attenuated murine infection
In order to assess infectivity, 1X104 spirochetes (wild type, rrp1/pdeA deletion
and complemented strains) were subcutaneously injected into mice. At 3 days postinoculation, blood was collected and the presence of spirochetes was assessed by
dark-field microscopy and by fluorescent detection of GFP. This collection continued
daily for 12 days. The average spirochete load for the mice (n=3) is shown in Figure 22.
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Figure 21. B. hermsii cells lacking pdeA accumulate cyclic-di-GMP compared to
the wild type and rrp1 mutant. To determine the intracellular levels of cyclic-di-GMP,
HPLC chromatograms of acid soluble extracts were prepared from B. hermsii wild type
(green peak), pdeA/rrp1 deletion mutant (blue peak), and its complemented strain (pink
peak) (A and B). The chromatographic profile of a c-di-GMP standard is depicted as a
dotted line in both A and B. The peak observed in the !pdeA strain was confirmed by
addition of cyclic-di-GMP standard to the !pdeA extract. HPLC chromatogram of the
unspiked extract of pdeA deletion mutant (blue peak) in comparison with c-di-GMP
spiked extract (red peak) (C).
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The wild type, BhDAHrrp1::kanR and BhDAHpdeA::kanR strains all displayed
similar levels of spirochetemia in the blood, with observable spirochetes in 3 out of 3
mice at the two days displaying peaks (Day 4 and Day 10). The BhDAH"rrp1 and
BhDAH"pdeA mutant cells displayed very different patterns of spirochetemia. While we
were never able to detect the BhDAH"rrp1 spirochetes in blood, the BhDAH"pdeA
mutant strain was were detectable at very low levels. BhDAH"pdeA demonstrated
observable spirochetes in the blood, concurrent with the initial peak observed in the
control strains. Additionally, spirochetes were observed in this strain at Day 8 (in 1 of 3
mice) and Day 13 (in 2 of 3 mice).
In order to further assess infectivity, serum was collected from the same mice at
4 weeks post-inoculation and used to determine seroconversion through ELISA and
western blotting (Figure 23A and B). Mice infected with wild type, BhDAHrrp1::kanR,
and BhDAHpdeA::kanR all had equivalent IgG titers while the BhDAH"rrp1 and
BhDAH"pdeA both displayed a significant 3-fold reduction in IgG titer. In an effort to
compare the IgG responses of the infected mice, the pattern of antigen recognition was
assessed by blotting B. hermsii DAH whole cell lysates onto PVDF and screening the
blots with equivalent amounts of serum from each infected mouse. Similar to the results
obtained in the ELISA, the immunoblot showed attenuation in antigenic recognition by
mice infected with the rrp1 and pdeA deletion strains. These data suggest that proper
regulation of c-di-GMP levels is required for productive B. hermsii infection. This
analysis was performed in collaboration with Dr. Lee T. Szkotnicki.
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Figure 22. Loss of both rrp1 and pdeA result in an attenuated murine infection.
Infectivity of both rrp1 and pdeA mutants were determined by subcutaneously needle
inoculation of 104 spirochetes in C3H-HeJ mice (3 mice per Borrelia genotype).
Spirochetemia was assessed from days 3-14 and spirochetes/mL of blood were
calculated using enumeration of 10 40x fields at each day. Average numbers from each
time point were graphed and representative peaks are shown in the graph.
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Figure 23. Serological analysis of mice infected with rrp1 and pdeA deletion
mutants. Seroconversion was assessed 4 weeks post-infection by whole cell ELISA
and western blot. Serum was harvested from infected mice and IgG titers were
assessed by ELISA (A) and patterns of antigen recognition were assessed by
immunoblotting against B. burgdorferi whole cell lysates (B).
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B)
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Characterization of the roles of PdeA and Rrp1 in motility and chemotaxis
Recent work in B. burgdorferi has demonstrated that cells lacking either Rrp1 or
PdeA display dramatic motility and chemotaxis defects (80, 125, 160). This combined
with other previous work in Vibrio, Escherichia, and Salmonella, suggests that altered
motility may play a role in the attenuation of the mutant B. hermsii infectivity (41, 79, 88,
111, 117, 134). We assessed the effects of Rrp1 and PdeA on the B.hermsii motility by
observing and recording cell movement in the presence of 1% methylcellulose.
Subsequent movies were used to calculate the average velocity and motility patterns of
the TBRF spirochetes. All strains displayed similar patterns of wave propagation,
average run speed and average number of stops/reverses (Figure 24A). Additionally
we assessed motility using agarose swarming assays. Only cells lacking pdeA
displayed a significant reduction in swarming diameter compared to the other 4 strains
used in all studies (Figure 24B). Finally, we assessed chemotaxis towards a known B.
burgdorferi chemoattractant, N-acetyl-D-glucosamine (NAG). NAG is a monomer of
chitin, a molecule abundant in ticks, which is required for growth of B. burgdorferi in
culture. Wild type B. hermsii and BhDAH!pdeA are equally attracted to NAG.
Conversely, the rrp1 containing strain showed reduced attraction to NAG. Taken
together, levels of c-di-GMP appear to be important in coordination of motility and
chemotaxis (Figure 24C). Motility analyses were performed by Dr. Lee. T. Szkotnicki.

Discussion
Cyclic di-GMP is an integrally important bacterial second messenger that has
been linked to pathogenesis in a number of different microorganisms including V.

129

Figure 24. Characterization of PdeA and Rrp1 mutants effect on motility and
chemotaxis. Translational movement patterns were obtained by capturing DIC
microscopy movies of the wild type mutant and complement strains. Motion tracking
software was used to display the movement patterns of the spirochetes. Stills taken
from representative movies are shown in (A). The ability of the B. hermsii mutants to
swarm in semi-solid BSK plates was determined as described for B. burgdorferi.
Motility defects were found to be statistically significant (B). Attraction towards N-acetylD-glucosamine was determined by use of a modified capillary assay as described in the
methods and materials and text (C).
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cholerae, E. coli, S. enterica, P. aeruginosa, and B. burgdorferi among others. Results
have shown effects of cyclic di-GMP on locomotion, biofilm formation, chemotaxis, as
well as changes in gene expression (19, 20, 58, 71, 82, 92, 100, 105, 111, 116, 125,
126, 160). Some of the more recent work has been focused on the elucidation of the
role of c-di-GMP in the Lyme disease spirochete B. burgdorferi. In fact, several recent
papers have detailed allelic replacement and analysis of the sole diguanylate cyclase
(rrp1), EAL domain-containing phosphodiesterase (pdeA), HD-GYP domain-containing
protein (pdeB), and the PilZ domain-containing protein of BbB31 (PlzA) (28, 58, 68, 80,
116, 125, 159, 160).
The goal of this study was to bring TBRF spirochetes into the forefront of the cdi-GMP signaling field as a model organism for its study. Much like the Lyme
spirochete, B. burgdorferi, B. hermsii provides an ideal system in which to study c-diGMP-mediated regulation, as its genome contains only a single copy of the genes
required to synthesize and degrade cyclic di-GMP. A significant difference between
these species is the fact that B. hermsii is capable of reaching truly staggering numbers
in the host animal’s blood (51). The large number and swift peaking of spirochetes in
the blood allows for simple observation of infection, and will allow for monitoring of gene
expression and various phenotypes at different time points during infection. This offers
an advantage over the Lyme disease model in that more time points can be taken and
fewer animals need be used. Thus, a wider depth of knowledge of signaling in this
unique organism will be obtained.
Initially, we identified genes responsible for c-di-GMP metabolism, and
subsequent in vitro experimentation provided evidence that the PdeA and Rrp1
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components of the B. hermsii c-di-GMP signaling pathway are active enzymes capable
of the breakdown and synthesis of c-di-GMP, respectively (58, 135, 160). Here, we
demonstrate that Rrp1 of B. hermsii is an active DGC upon phosphorylation of an
aspartic acid of the receiver domain (Figure 18). While we artificially phosphorylated
the protein using AcP, we believe that the cognate histidine kinase of Rrp1, Hpk1,
activates the hybrid response regulator/DGC within bacterial cells. Of note, is that when
unphosphorylated Rrp1 is incubated with GTP, we observed 2 peaks shifted to the left
relative to retention volume of GTP. One possibility is that non-activated Rrp1 is
capable of cleaving the # or $ phosphates of GTP, while not being able to carry out any
cyclase activity. It is unknown what, if any, relevance this activity has to either relapsing
fever or Lyme Borrelia biology.
As was demonstrated for PdeA from B. burgdorferi, PdeA from B. hermsii is an
EAL domain-containing PDE capable of the specific breakdown of c-di-GMP into l-diGMP. Additionally, PdeA from B. hermsii did not demonstrate an increase in activity in
the presence of Mn2+ as was the case for PdeA from B. burgdorferi (160). Differences
in divalent specificity may be because of slight differences in protein sequence and
structure, such that proper coordination of the divalent cation at the active site is
achieved (116, 159, 160). Taken together, B. hermsii possesses the components
needed to synthesize c-di-GMP in a signal/activation-dependant manner, as well as
degrade it into l-di-GMP. It is unknown what, if any, effects l-di-GMP might have in the
Borrelia or in other species. However, it is important to note that these opposing
activities may regulate processes important in motility and mammalian infection.
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As previously described, genetic manipulation of B. hermsii has recently come to
the forefront of emerging techniques important in understanding these unique
organisms (12, 53). These important molecular tools will be paramount in describing
virulence factors important in the B. hermsii disease process. Here, we deleted the
open reading frames encoding the proteins PdeA and Rrp1, by allelic exchange with a
gentamycin resistance-gfp cassette. We also created strains that were functionally
complemented in cis with a kanamycin resistance-gfp cassette. Initial growth analyses
demonstrated equal growth rates at 23°C, 33°C, and 37°C of all strains (Figure 20D).
Additional testing revealed that both linear plasmid composition (Figure 20E) and
protein profile (Figure 20F) are indistinguishable for wild type and mutant strains.
It is currently unknown what signal results in the activation of Rrp1 and thus in
the production of cyclic-di-GMP. We have been unsuccessful in detecting c-di-GMP in
wild type B. hermsii growing in an in vitro setting. These results are similar to those
described in Kostick et al. (80) in that we were also unable to detect cyclic-di-GMP in
the wild-type B. burgdorferi or rrp1 deletion strains. However, we successfully
demonstrated by quantitative HPLC that our pdeA null strain does accumulate cyclic-diGMP. It may be that the signal(s) responsible for Hpk1/Rrp1 activation are not present
under in vitro conditions, as c-di-GMP is not robustly present in wild type and rrp1
deletion strains. These signals may be present in tick environment, as it has been
shown that the proteins involved in c-di-GMP synthesis/breakdown and binding have
their largest effects in tick environment (28, 58, 68, 80, 116, 125, 159, 160).
In order to assess the effects of the c-di-GMP signaling components of B. hermsii
on mammalian infectivity, we infected C3H/HeJ mice (n=3) subcutaneously with 104

135

spirochetes of BhDAH"rrp1, BhDAH"pdeA, BhDAHpdeA::kanR, BhDAHrrp1::kanR, and
the wild type strains. Spirochete burden in the blood was analyzed each day for 21
days via microscopy and counting, and infectivity was also assessed via serology using
ELISA and western blotting analysis. Via microscopy, we observed zero spirochetes in
BhDAH"rrp1, and seldom viewed spirochetes in BhDAH"pdeA at any time point.
Conversely, wild type B. hermsii and both complemented strains were counted in blood,
and peaks of spirochetemic relapses coincided with each other. Additionally, we
assessed antibody titers by ELISA, and observed a three-fold lower titer in both "pdeA
and "rrp1 as compared to wild type B. hermsii DAH and complemented strains. We
also assessed seroconversion by screening immobilized B. hermsii whole cell lysate
with serum collected from the infected mice. While we observed seroconversion in all
cases, band intensity was markedly reduced when sera from mice infected with "pdeA
and "rrp1 was employed. Based upon these observations, we conclude that PdeA and
Rrp1 are not essential for infection, yet they are required for establishment of a
productive relapsing fever infection. It remains to be determined why the deletion
mutants failed to thrive in the mammalian environment, and why there was seldom
observation of these strains in the blood, i.e. why they display attenuated infectivity.
One possibility is that they are unable to reach the bloodstream when inoculated
subcutaneously, due to deficiencies in motility and/or chemotaxis, as well as other
physiological processes. Another possibility is that these strains are rapidly cleared,
while a few persisting cells are able to cause infection long enough to elicit an immune
response without causing infection. This is different than the Rrp1 and PdeA signaling
components of the Lyme disease spirochete B. burgdorferi, where Rrp1 is dispensable
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for productive infection and PdeA is absolutely necessary to cause infection. Both
diseases and disease processes are quite different, and it may be that these signaling
components and c-di-GMP itself, function differently between the different species.
Because c-di-GMP has been described to affect motility and chemotaxis in B.
burgodorferi and other organisms, we assessed the ability of B. hermsii DAH deficient in
Rrp1 and PdeA, to move and chemotax normally as compared to the parental strain
(116, 117, 134, 160, 169) Microscopic analysis of movement demonstrated that rrp1
and pdeA null strains behave similarly to wild type B. hermsii DAH, as they all displayed
similar patterns of wave propagation, average run speed and average number of
stops/reverses. Additionally, we assessed motility using the well-described soft agar
swarming assay. Only the pdeA null strain demonstrated a reduction in swarming,
indicating that elevated levels of c-di-GMP may inhibit motility on or in surfaces that
support spirochetal growth. This is similar to what has been described in B. burgdorferi,
however, the phenotype exhibited appears to be much more affected by elevated c-diGMP levels in B. hermsii. In fact high levels of cyclic-di-GMP have been shown in other
systems to be indicative of a sedentary, non-motile existence (69). Differences in
motility control may be affected adversely at the level of protein-protein, protein-RNA, or
protein-DNA interactions, as controlled by a yet-to-be described means of c-di-GMPmediated motility control. Such interactions have been described in other organisms
such as E. coli and V. cholerae (49, 76, 150). Finally, the chemotactic response was
decreased in the rrp1 null strain, indicating that Rrp1 and thus c-di-GMP positively
regulates chemotaxis of B. hermsii towards N-acetyl glucosamine. This result is
surprisingly similar to those recently described in Kostick et al. (80).
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In summary, this study demonstrates that Rrp1 and PdeA of B. hermsii regulate
processes important in the infection and motility of the TBRF spirochetes. Deletion of
both rrp1 and pdeA prevented the establishment of a productive population during
murine infection. While the deletion of rrp1 attenuated swarming motility of B. hermsii,
deletion of pdeA did not. Similarly to B. burgdorferi, Rrp1 was found to be important in
chemotactic responses. Both motility and chemotactic responses are likely to be critical
for processes important for B. hermsii mammalian infection and potentially, survival in
the tick environment. Unfortunately, access to Ornithodoros hermsii ticks is extremely
limited and these experiments were unable to be performed. Since both Rrp1 and PdeA
have DGC and PDE activity, respectively, it is likely important that levels of c-di-GMP
are crucial for the phenotypes observed. Because the Rrp1 and PdeA-associated
phenotypes in B. hermsii are slightly different than those observed in B. burgdorferi, it
may be that c-di-GMP works in a different manner in both of these systems. It will be
important to consider these differences in future studies of both organisms.
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Chapter 6: Conclusions

Both Lyme disease and tick-borne relapsing fever (TBRF) are diseases of
worldwide health importance. The Lyme disease Borrelia exist in nature in an enzootic
cycle between Ixodes hard-bodied tick vectors and mammalian reservoirs, and the
TBRF Borrelia exist in an enzootic niche involving Ornithodoros soft-bodied tick vectors
and mammals. While both groups of Borrelia exist in diverse reservoirs, geographic
locations, and cause different diseses, they have both evolved and maintained the
same and/or similar putative physiological and genetic regulatory mechanisms. As is
such, both groups of Borrelia have the capacity to rapidly adapt to changing
environmental conditions in ticks/mammals. One way in which they are able to do this
is through the use of one of the two two-component regulatory systems (TCRS) with
global regulatory capabilities. Of interest is the TCRS involving Hpk1/Rrp1 and the
production of the second messenger c-di-GMP. Because c-di-GMP must interact with
downstream effector molecules in order to translate its synthesis into physiological
outcomes, we analyzed the PilZ domain-containing proteins PlzA and PlzB of B.
burgdorferi with the goal of defining functions of PlzA and PlzB, as well as building a
better understanding c-di-GMP signaling in the Lyme disease spirochetes. It was
determined that plzA is universally distributed amonst B. burgdorferi sensu lato, that it is
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upregulated in ticks during feeding, and that its expression is maintained during
mammalian infection. These data are similar to what was seen for rrp1, as both have
similar patterns of expression. With the fact that Rrp1 is the lone DGC encoded for in
the Borrelia genome, it is not surprising that a proposed effector protein would be
important during similar times during the enzootic cycle. Additionally, it was
demonstrated that both PlzA and PlzB bind c-di-GMP with high specificity, and that this
binding is accomplished via arginine residues that are a part of c-di-GMP binding switch
(in terms of PlzA, and likely PlzB).
The distribution of plzB was also assessed in a diverse range of strains, and was
found to be carried in about 40% of isolates tested. What advantage PlzB offers such
isolates remains unclear. PlzA was shown to be important in the motility of B.
burgdorferi, as its deletion results in decreases swarming, slower velocity, and
decreased flexing. This aberrant motility may provide a clue as to why deletion of plzA
results in noninfective spirochetes. Simply, motility as regulated by c-di-GMP and PlzA,
may be important for transmission to the mammalian host, as well as dissemination
through host tissues, processes that are likely important in host survival and evasion.
PlzB was unable to compensate for a loss of PlzA function in all phenotypes examined.
Taken together, these studies indicate that PlzA is essential in successful completion of
the enzootic cycle of B. burgdorferi, and that it may directly or indirectly regulate the
motility of this unique organism.
Finally, we assessed the DGC, Rrp1, and EAL PDE, PdeA of B. hermsii. Both
proteins maintained their enzymatic activity as described for B. burgdorferi, and both
were shown to be necessary for productive infection TBRF infection. PdeA, but not
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Rrp1, was shown to be important in the positive regulation of motility. Interestingly,
Rrp1 of B. burgdorferi was nonessential for murine infection and was shown to be a
positive regulator of motility. Rrp1 of B. hermsii was also shown to be important in the
chemotaxis towards NAG. While these proteins have similar functions, it may be that
the regulation and/or activities of the B. hermsii c-di-GMP signaling components are
needed during different processes important for their survival in nature.
Taken together, the work provided here demonstrates an importance for c-diGMP and c-di-GMP signaling in the Lyme disease and tick-borne relapsing fever
Borrelia. While all of the answers involving the importance of c-di-GMP and its
mechanism(s) of action are not clear, the work here provides a framework for future
experiments that will allow for the synthesis of a well-defined model of c-di-GMP
signaling in Borrelia spp. A better understanding of c-di-GMP signaling in the Borrelia
may shine light onto other c-di-GMP signaling networks in other bacteria and may
provide a pillar for future drug discovery and or treatments.
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